| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 6.76e-08 | 9 | 284 | 5 | GO:0016308 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 2.85e-06 | 3 | 284 | 3 | GO:0000285 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-kinase activity | 2.85e-06 | 3 | 284 | 3 | GO:0052810 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RIPK1 MARK3 CLK4 OBSCN PAK6 BCR PTK2B GRK2 MAST4 CLK2 RPS6KL1 MAP3K8 PKMYT1 PIKFYVE EGFR MTOR PRKDC MAP2K2 EIF2AK2 | 2.33e-05 | 446 | 284 | 19 | GO:0004674 |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 ABCC4 SETX MYO1D MYO1E ABCA13 ZGRF1 PSMC3 SRCAP ABCA9 DHX8 IQCA1L KIF28P DYNC1H1 RAD51 DDX60 KATNA1 FIGN NLRP3 DNAH1 EIF4A1 DNAH17 POLQ | 2.52e-05 | 614 | 284 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 2.89e-05 | 26 | 284 | 5 | GO:0052742 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | RIPK1 MARK3 CLK4 OBSCN PAK6 BCR MAST4 CLK2 RPS6KL1 MAP3K8 PKMYT1 PIKFYVE MTOR PRKDC MAP2K2 EIF2AK2 | 6.92e-05 | 363 | 284 | 16 | GO:0106310 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PCYT1A RIPK1 MARK3 CLK4 OBSCN CCND1 PAK6 BCR PTK2B PARP4 GRK2 MAST4 CLK2 PIP4K2A DKC1 PIP5K1A PIP5K1B RPS6KL1 POLA1 MAP3K8 PIP5K1C PKMYT1 PIKFYVE EGFR MTOR PRKDC POLQ MAP2K2 EIF2AK2 | 7.62e-05 | 938 | 284 | 29 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | RIPK1 MARK3 CLK4 OBSCN CCND1 PAK6 BCR PTK2B GRK2 MAST4 CLK2 PIP4K2A PIP5K1A PIP5K1B RPS6KL1 MAP3K8 PIP5K1C PKMYT1 PIKFYVE EGFR MTOR PRKDC MAP2K2 EIF2AK2 | 8.33e-05 | 709 | 284 | 24 | GO:0016773 |
| GeneOntologyMolecularFunction | transcription termination site sequence-specific DNA binding | 2.02e-04 | 2 | 284 | 2 | GO:0001147 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 2.02e-04 | 2 | 284 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC4 MYO1E ABCA13 PSMC3 SRCAP ABCA9 DHX8 IQCA1L KIF28P DYNC1H1 RAD51 DDX60 KATNA1 FIGN NLRP3 EIF4A1 POLQ | 2.08e-04 | 441 | 284 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | microtubule severing ATPase activity | 2.24e-04 | 9 | 284 | 3 | GO:0008568 | |
| GeneOntologyMolecularFunction | kinase activity | RIPK1 MARK3 CLK4 OBSCN CCND1 PAK6 BCR PTK2B GRK2 MAST4 CLK2 PIP4K2A PIP5K1A PIP5K1B RPS6KL1 MAP3K8 PIP5K1C PKMYT1 PIKFYVE EGFR MTOR PRKDC MAP2K2 EIF2AK2 | 2.55e-04 | 764 | 284 | 24 | GO:0016301 |
| GeneOntologyMolecularFunction | lipid kinase activity | 2.77e-04 | 41 | 284 | 5 | GO:0001727 | |
| GeneOntologyMolecularFunction | protein kinase activity | RIPK1 MARK3 CLK4 OBSCN CCND1 PAK6 BCR PTK2B GRK2 MAST4 CLK2 RPS6KL1 MAP3K8 PKMYT1 PIKFYVE EGFR MTOR PRKDC MAP2K2 EIF2AK2 | 3.98e-04 | 600 | 284 | 20 | GO:0004672 |
| GeneOntologyMolecularFunction | signaling adaptor activity | 5.24e-04 | 129 | 284 | 8 | GO:0035591 | |
| GeneOntologyMolecularFunction | Krueppel-associated box domain binding | 5.99e-04 | 3 | 284 | 2 | GO:0035851 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.14e-03 | 15 | 284 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 1.14e-03 | 15 | 284 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | L27 domain binding | 1.19e-03 | 4 | 284 | 2 | GO:0097016 | |
| GeneOntologyBiologicalProcess | peptidyl-serine autophosphorylation | 4.03e-06 | 9 | 281 | 4 | GO:0036289 | |
| GeneOntologyBiologicalProcess | fungiform papilla formation | 9.91e-06 | 4 | 281 | 3 | GO:0061198 | |
| GeneOntologyBiologicalProcess | organelle assembly | ABCC4 SYNPO2 ODAD1 OBSCN KAT2A CFAP65 DNAJB13 PTK2B NTNG2 SYNE2 PIP4K2A HPS1 POC1B SCFD1 DYNC1H1 CFAP47 RPGRIP1 SYNE1 HPS3 DNAH1 WDR19 PIKFYVE RAB3GAP1 TIA1 MTOR CCNB2 DNAH17 TTC21B CFAP74 MYOM2 PRKDC SPAG17 CAPRIN1 HDAC2 | 1.47e-05 | 1138 | 281 | 34 | GO:0070925 |
| GeneOntologyBiologicalProcess | nucleus localization | 2.77e-05 | 44 | 281 | 6 | GO:0051647 | |
| GeneOntologyBiologicalProcess | hair follicle placode formation | 4.85e-05 | 6 | 281 | 3 | GO:0060789 | |
| GeneOntologyBiologicalProcess | fungiform papilla morphogenesis | 4.85e-05 | 6 | 281 | 3 | GO:0061197 | |
| GeneOntologyCellularComponent | leading edge membrane | MYO1D ITGAV SYNE2 PIP5K1A TESC PLA2G4F GPER1 DOCK8 GRIA1 PIP5K1C EGFR | 1.27e-04 | 210 | 279 | 11 | GO:0031256 |
| GeneOntologyCellularComponent | postsynaptic density | DLG5 LIN7C PAK6 BCR LIN7A PTK2B LRFN2 GRK2 AFDN PLCB4 SHANK1 GPER1 GRIA1 PIP5K1C ADAM22 CTNNB1 EPB41L1 | 1.29e-04 | 451 | 279 | 17 | GO:0014069 |
| Domain | PIP5K | 3.87e-08 | 8 | 279 | 5 | PF01504 | |
| Domain | PIPK | 3.87e-08 | 8 | 279 | 5 | PS51455 | |
| Domain | - | 3.87e-08 | 8 | 279 | 5 | 3.30.810.10 | |
| Domain | PIPKc | 3.87e-08 | 8 | 279 | 5 | SM00330 | |
| Domain | - | 3.87e-08 | 8 | 279 | 5 | 3.30.800.10 | |
| Domain | PInositol-4-P-5-kinase_N | 3.87e-08 | 8 | 279 | 5 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 3.87e-08 | 8 | 279 | 5 | IPR027483 | |
| Domain | PInositol-4-P-5-kinase_core | 3.87e-08 | 8 | 279 | 5 | IPR002498 | |
| Domain | PInositol-4-P-5-kinase | 1.65e-06 | 7 | 279 | 4 | IPR023610 | |
| Domain | PDZ | DLG5 SYNPO2 LIN7C LIN7A MAST4 AFDN SIPA1L2 SHANK1 ARHGAP23 RGS12 SNTB1 | 8.97e-06 | 141 | 279 | 11 | PF00595 |
| Domain | PDZ | DLG5 SYNPO2 LIN7C LIN7A MAST4 AFDN SIPA1L2 SHANK1 ARHGAP23 RGS12 SNTB1 | 1.42e-05 | 148 | 279 | 11 | SM00228 |
| Domain | ARM-type_fold | USP34 RSPH14 CAND1 TRIP12 LYST UNC79 DOCK1 DOCK8 MROH2A NBEA IPO4 ECPAS MTOR PKP3 FHOD1 PRKDC CTNNB1 | 1.47e-05 | 339 | 279 | 17 | IPR016024 |
| Domain | - | DLG5 SYNPO2 LIN7C LIN7A MAST4 AFDN SIPA1L2 SHANK1 ARHGAP23 RGS12 SNTB1 | 1.61e-05 | 150 | 279 | 11 | 2.30.42.10 |
| Domain | PDZ | DLG5 SYNPO2 LIN7C LIN7A MAST4 AFDN SIPA1L2 SHANK1 ARHGAP23 RGS12 SNTB1 | 1.72e-05 | 151 | 279 | 11 | PS50106 |
| Domain | PDZ | DLG5 SYNPO2 LIN7C LIN7A MAST4 AFDN SIPA1L2 SHANK1 ARHGAP23 RGS12 SNTB1 | 1.83e-05 | 152 | 279 | 11 | IPR001478 |
| Domain | ARM-like | RSPH14 CAND1 SETX TRIP12 DOCK8 MROH2A NBEA IPO4 ECPAS MTOR PKP3 FHOD1 PRKDC CTNNB1 | 5.87e-05 | 270 | 279 | 14 | IPR011989 |
| Domain | - | DLG5 ABCC4 SETX MYO1E ABCA13 ZGRF1 NDST4 PSMC3 SRCAP ABCA9 DHX8 RHOBTB2 HS3ST3B1 HS3ST3A1 DYNC1H1 RAD51 WSCD1 DDX60 KATNA1 FIGN DNAH1 GTPBP2 GTPBP8 EIF4A1 POLQ | 1.48e-04 | 746 | 279 | 25 | 3.40.50.300 |
| Domain | C2 | 1.57e-04 | 131 | 279 | 9 | PF00168 | |
| Domain | P-loop_NTPase | DLG5 ABCC4 SETX MYO1D MYO1E ABCA13 ZGRF1 NDST4 PSMC3 SRCAP ABCA9 DHX8 RHOBTB2 HS3ST3B1 HS3ST3A1 DYNC1H1 RAD51 WSCD1 DDX60 KATNA1 FIGN NLRP3 DNAH1 GTPBP2 GTPBP8 EIF4A1 POLQ | 1.84e-04 | 848 | 279 | 27 | IPR027417 |
| Domain | C2 | 2.20e-04 | 137 | 279 | 9 | SM00239 | |
| Domain | Otx_TF | 2.22e-04 | 2 | 279 | 2 | IPR003025 | |
| Domain | SPIN-2 | 2.22e-04 | 2 | 279 | 2 | IPR029564 | |
| Domain | C2 | 2.88e-04 | 142 | 279 | 9 | PS50004 | |
| Domain | HEAT_REPEAT | 6.20e-04 | 70 | 279 | 6 | PS50077 | |
| Domain | Otx_TF_C | 6.60e-04 | 3 | 279 | 2 | IPR013851 | |
| Domain | TF_Otx | 6.60e-04 | 3 | 279 | 2 | PF03529 | |
| Domain | PH_dom-like | CYTH3 OBSCN MCF2 BCR LYST PTK2B GRK2 PLCB4 ARHGAP23 NBEA RGS12 GTF2H1 CADPS SNTB1 EPB41L1 PLCE1 | 7.14e-04 | 426 | 279 | 16 | IPR011993 |
| Domain | C2_dom | 8.21e-04 | 164 | 279 | 9 | IPR000008 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 5.62e-06 | 46 | 215 | 7 | M48317 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 8.68e-06 | 49 | 215 | 7 | M40046 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 1.68e-05 | 54 | 215 | 7 | M3896 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY | 6.76e-05 | 6 | 215 | 3 | M47624 | |
| Pubmed | CPA4 PCYT1A CAND1 SETX LIN7C CENPB ERAP1 PSMC3 ITGAV TRIP12 SERPINB6 FBXO3 HPRT1 SYNE2 PIP5K1A PLCB4 DYNC1H1 ATPAF1 NEDD4L ESYT1 L1CAM FARSB UFL1 AKAP12 SART1 EGFR PKP3 EIF4A1 UGGT2 NAA30 HAGH PRKDC CTNNB1 EIF2AK2 CAPRIN1 HDAC1 | 1.94e-10 | 1297 | 285 | 36 | 33545068 | |
| Pubmed | CAND1 MYO1D MYO1E MARK3 PSMC3 PSMD3 BCR MRPS22 PTK2B STXBP1 GRK2 PNPLA6 SACS PIP4K2A AFDN SIPA1L2 IMMT DYNC1H1 SDHA SHANK1 ADCY4 BIN1 NEDD4L ARHGAP23 DOCK8 SYNE1 L1CAM FARSB GRIA1 NBEA SLC1A3 ADAM22 CADPS KIAA1217 TMPO CTNNB1 CAPRIN1 EPB41L1 | 2.04e-10 | 1431 | 285 | 38 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DLG5 MYO1D MYO1E MARK3 PSMD3 TRIP12 MRPS22 DHX8 PNPLA6 ASCC2 IMMT DYNC1H1 SDHA XRN2 ESYT1 DDX60 FARSB IPO4 APOBEC3B SART1 HARS2 GTF2H1 EGFR PKP3 KIAA1217 FHOD1 UTP4 EIF4A1 TMPO PRKDC NUP93 CTNNB1 EIF2AK2 CAPRIN1 HDAC1 | 3.27e-10 | 1257 | 285 | 35 | 36526897 |
| Pubmed | 7.39e-10 | 7 | 285 | 5 | 15018809 | ||
| Pubmed | 1.96e-09 | 8 | 285 | 5 | 15046600 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CPA4 IL18 CAND1 SETX PSMC3 PSMD3 SRCAP TRIP12 SERPINB6 PNPLA6 PIP4K2A DKC1 AFDN SCFD1 IMMT DYNC1H1 MPO XRN2 ARHGAP23 SPTLC2 POLA1 ESYT1 RPP30 FARSB IPO4 SART1 RAB3GAP1 GTF2H1 FHOD1 UTP4 EIF4A1 PRKDC NUP93 EIF2AK2 CAPRIN1 | 2.23e-09 | 1353 | 285 | 35 | 29467282 |
| Pubmed | UBA5 CAND1 PSMC3 PSMD3 PSMD8 DKC1 SCFD1 IMMT DYNC1H1 XRN2 POLA1 ESYT1 UFL1 IPO4 ECPAS MTOR TMPO PRKDC NUP93 CTNNB1 MAP2K2 HDAC1 HDAC2 | 3.96e-09 | 638 | 285 | 23 | 33239621 | |
| Pubmed | 4.42e-09 | 4 | 285 | 4 | 9535851 | ||
| Pubmed | USP34 CAND1 MYO1D PSMC3 PSMD3 PSMD8 BCR MRPS22 LIN7A FBXO3 HPRT1 ASCC2 DKC1 PIP5K1A SCFD1 USP15 IMMT SDHA ANAPC4 XRN2 RPP30 FARSB IPO4 NXN BTBD7 EIF4A1 TMPO INTS9 PRKDC NUP93 EIF2AK2 CAPRIN1 HDAC1 HDAC2 | 5.68e-09 | 1335 | 285 | 34 | 29229926 | |
| Pubmed | USP34 MYO1D PSMC3 TRIP12 DHX8 SYNE2 AFDN IMMT DYNC1H1 SDHA USP47 XRN2 POLA1 IPO4 ECPAS SART1 MTOR UTP4 EIF4A1 PRKDC NUP93 CAPRIN1 HDAC2 | 6.12e-09 | 653 | 285 | 23 | 22586326 | |
| Pubmed | DLG5 MARK3 FASTKD5 PSMD8 MRPS22 ZNF512B DNAJB13 PNPLA6 SACS SYNE2 ASCC2 PIP5K1A SCFD1 SIPA1L2 IMMT ATPAF1 SDHA LYRM4 ESYT1 SYNE1 RPP30 UFL1 IPO4 AKAP12 SLC5A3 PKMYT1 WDR19 RAB3GAP1 EGFR UTP4 TMPO UGGT2 CTNNB1 CAPRIN1 SNTB1 EPB41L1 | 7.23e-09 | 1487 | 285 | 36 | 33957083 | |
| Pubmed | CAND1 HECW1 CYTH3 BCR SYNE2 AFDN UNC79 DYNC1H1 SHANK1 BIN1 NEDD4L SYNE1 FARSB GRIA1 SPATA20 NBEA IPO4 SLC1A3 ADAM22 AKAP12 SART1 MTOR KIAA1217 EIF4A1 CTNNB1 CAPRIN1 EPB41L1 HDAC2 | 8.69e-09 | 963 | 285 | 28 | 28671696 | |
| Pubmed | PCYT1A PSMD3 FASTKD5 DHX8 ASCC2 SYPL1 PIP5K1A AFDN IMMT DYNC1H1 SDHA SPTLC2 ESYT1 IPO4 ECPAS RAB3GAP1 UTP4 TMPO NUP93 HDAC1 HDAC2 | 9.76e-09 | 560 | 285 | 21 | 35241646 | |
| Pubmed | ABCC4 CAND1 ERAP1 PSMC3 PSMD3 BCR PARP4 GRK2 PNPLA6 PIGA IMMT DYNC1H1 XRN2 DPY19L1 DOCK8 ESYT1 FARSB IPO4 ECPAS PKMYT1 MTOR FHOD1 EIF4A1 TMPO ABHD13 PRKDC NUP93 EIF2AK2 CAPRIN1 LMBRD1 NCKAP1L | 1.10e-08 | 1168 | 285 | 31 | 19946888 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 CAND1 LIN7C PSMC3 PSMD3 PSMD8 BCR MRPS22 LIN7A MDP1 FBXO3 PIP5K1A AFDN SIPA1L2 IMMT SDHA USP47 MPO SPTLC2 ESYT1 FARSB IPO4 ECPAS MTOR PKP3 PRKDC NUP93 SNTB1 | 1.11e-08 | 974 | 285 | 28 | 28675297 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | UBA5 CAND1 SETX PSMC3 PSMD3 TRIP12 DHX8 PARP4 DYNC1H1 DOCK1 XRN2 RBM45 DOCK8 SART1 PKP3 FHOD1 EIF4A1 TMPO PRKDC NUP93 MAP2K2 | 1.89e-08 | 582 | 285 | 21 | 20467437 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CAND1 MYO1D PSMC3 PSMD3 FASTKD5 PSMD8 DHX8 HPRT1 DKC1 AFDN SCFD1 TDRD6 IMMT DYNC1H1 SDHA ADCY4 XRN2 POLA1 ESYT1 SYNE1 FARSB UFL1 IPO4 ECPAS SART1 MTOR UTP4 EIF4A1 TMPO PRKDC NUP93 EIF2AK2 CAPRIN1 HDAC1 | 2.80e-08 | 1425 | 285 | 34 | 30948266 |
| Pubmed | MYO1E PSMC3 FASTKD5 PIP4K2A DKC1 AFDN TAF10 IMMT DYNC1H1 SDHA ESYT1 UFL1 IPO4 ECPAS NXN SART1 PKP3 TMPO PRKDC CTNNB1 MAP2K2 CAPRIN1 HDAC1 | 2.93e-08 | 711 | 285 | 23 | 33022573 | |
| Pubmed | DLG5 CAND1 LIN7C MYO1D MARK3 PSMC3 PSMD3 TRIP12 MRPS22 DHX8 ASCC2 USP15 IMMT DYNC1H1 SDHA RAD51 FARSB DNAH1 SART1 PKP3 UTP4 EIF4A1 TMPO PRKDC NUP93 CTNNB1 MAP2K2 EIF2AK2 CAPRIN1 HDAC1 HDAC2 | 4.85e-08 | 1247 | 285 | 31 | 27684187 | |
| Pubmed | Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. | 6.54e-08 | 6 | 285 | 4 | 14614850 | |
| Pubmed | 6.54e-08 | 6 | 285 | 4 | 20841379 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP34 CAND1 PSMC3 PSMD3 PSMD8 MRPS22 HPRT1 PIP5K1A LSM11 USP15 DYNC1H1 SDHA ESYT1 RPP30 FARSB IPO4 EIF4A1 PRKDC CTNNB1 HDAC2 | 6.75e-08 | 571 | 285 | 20 | 37167062 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CAND1 LIN7C CENPB MARK3 PSMC3 PSMD3 KAT2A BCR TRIP12 LIN7A DHX8 FBXO3 DKC1 USP27X USP15 IMMT USP47 NEDD4L RBM45 POLA1 IPO4 NXN SART1 KLHL15 UGGT2 NUP93 ZMYM6 | 8.11e-08 | 1005 | 285 | 27 | 19615732 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CAND1 MYO1D PSMD3 SRCAP TRIP12 DHX8 ZNF512B SACS HPRT1 SYNE2 DKC1 AFDN IMMT DYNC1H1 XRN2 NEDD4L SYNE1 UFL1 SART1 PKP3 UTP4 EIF4A1 TMPO PRKDC NUP93 CTNNB1 HDAC2 | 1.18e-07 | 1024 | 285 | 27 | 24711643 |
| Pubmed | MYO1D PSMD3 PSMD8 KAT2A SRCAP TRIP12 LYST STXBP1 SACS SYNE2 PIP4K2A DKC1 SIPA1L2 IMMT RPGRIP1 PCDHGC4 PCDHGA5 SYNE1 GRIA1 REL SART1 STS EIF4A1 TMPO CFAP74 UGGT2 MYOM2 PRKDC POLQ SPAG17 DOP1A HDAC1 HDAC2 | 1.20e-07 | 1442 | 285 | 33 | 35575683 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | USP34 RIPK1 MARK3 CLK4 PSMD3 FASTKD5 BCR LYST PTK2B CLK2 PIP4K2A TAF10 USP27X ANAPC4 ARHGAP23 DPY19L1 GTF2H1 EGFR RTL1 CCNB2 CTNNB1 MAP2K2 SNTB1 HDAC1 HDAC2 | 1.66e-07 | 910 | 285 | 25 | 36736316 |
| Pubmed | PSMD3 ITGAV IQCA1L SPIN2A DKC1 SIPA1L2 MPO ESYT1 ECM2 MROH2A COX11 DNAH1 GTPBP2 CADPS TMPO POLQ EIF2AK2 HDAC2 | 1.85e-07 | 496 | 285 | 18 | 31343991 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | PSMC3 PSMD3 BCR MRPS22 DYNC1H1 RPP30 IPO4 EIF4A1 TMPO PRKDC HDAC1 HDAC2 | 2.02e-07 | 211 | 285 | 12 | 17314511 |
| Pubmed | 2.22e-07 | 105 | 285 | 9 | 9628581 | ||
| Pubmed | DLG5 PSMC3 PSMD3 TRIP12 USP15 DYNC1H1 USP47 ESYT1 RPP30 UFL1 HARS2 TMPO PRKDC CTNNB1 HDAC1 HDAC2 | 2.39e-07 | 399 | 285 | 16 | 37536630 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | CAND1 PSMC3 PSMD3 IMMT DYNC1H1 SDHA XRN2 NXN EIF4A1 TMPO PRKDC | 2.41e-07 | 175 | 285 | 11 | 25756610 |
| Pubmed | 3.01e-07 | 8 | 285 | 4 | 20622009 | ||
| Pubmed | USP34 PCYT1A CAND1 ZNF234 MYO1E CYTH3 HLCS TRIP12 ME3 CNOT8 ZNF512B CYRIA STXBP1 SACS AFDN IMMT DYNC1H1 SDHA USP47 SHANK1 BIN1 XRN2 SYNE1 NBEA ADAM22 WDR19 CADPS EIF4A1 PRKDC CAPRIN1 | 3.08e-07 | 1285 | 285 | 30 | 35914814 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CAND1 PSMC3 FASTKD5 PSMD8 TRIP12 PNPLA6 SCFD1 IMMT DYNC1H1 SDHA SPTLC2 ESYT1 FARSB UFL1 IPO4 ECPAS RAB3GAP1 MTOR CCNB2 EIF4A1 TMPO UGGT2 PRKDC NUP93 CTNNB1 | 3.14e-07 | 942 | 285 | 25 | 31073040 |
| Pubmed | USP34 CAND1 MYO1E CENPB MARK3 PSMC3 PSMD3 FASTKD5 CCND1 MRPS22 SYNE2 ASCC2 DKC1 SCFD1 DYNC1H1 SDHA XRN2 SPTLC2 ESYT1 DDX60 FARSB UFL1 IPO4 ECPAS RAB3GAP1 MTOR EIF4A1 TMPO PRKDC NUP93 CTNNB1 CAPRIN1 | 3.60e-07 | 1440 | 285 | 32 | 30833792 | |
| Pubmed | MARK3 ITGAV STXBP1 PIP5K1A SCFD1 SIPA1L2 SDHA NEDD4L ESYT1 UFL1 AKAP12 EGFR KIAA1217 CTNNB1 SNTB1 EPB41L1 | 4.89e-07 | 421 | 285 | 16 | 36976175 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 DLG5 SETX MYO1D ZGRF1 SRCAP BCR HPRT1 PIP4K2A TONSL SIPA1L2 XRN2 IPO4 PIKFYVE CCNB2 KIAA1217 UTP4 CTNNB1 ZMYM6 | 4.92e-07 | 588 | 285 | 19 | 38580884 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAND1 HLCS PSMC3 PSMD3 FASTKD5 TRIP12 MRPS22 CLK2 HPRT1 PIP4K2A DKC1 SCFD1 TAF10 DYNC1H1 SDHA XRN2 ESYT1 FARSB UFL1 IPO4 APOBEC3B UTP4 EIF4A1 TMPO PRKDC NUP93 MAP2K2 EIF2AK2 HDAC1 HDAC2 | 5.23e-07 | 1318 | 285 | 30 | 30463901 |
| Pubmed | 5.39e-07 | 9 | 285 | 4 | 10193444 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 20574004 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 15791567 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 27174093 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 34755743 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 22942276 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 33472039 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 14681219 | ||
| Pubmed | PIP5KIβ selectively modulates apical endocytosis in polarized renal epithelial cells. | 5.45e-07 | 3 | 285 | 3 | 23342003 | |
| Pubmed | 5.63e-07 | 86 | 285 | 8 | 26885983 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | CAND1 PTK2B STXBP1 SACS DYNC1H1 SHANK1 SYNE1 GRIA1 NBEA SLC1A3 ADAM22 MTOR EPB41L1 | 6.69e-07 | 281 | 285 | 13 | 28706196 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PCYT1A CAND1 MYO1E SEC24A PSMC3 PSMD3 MRPS22 DHX8 SERPINB6 FBXO3 HPRT1 SYNE2 DKC1 IMMT DYNC1H1 SDHA NEDD4L POLA1 FARSB UFL1 SLC1A3 SART1 EGFR PKP3 FHOD1 EIF4A1 HAGH PRKDC EIF2AK2 CAPRIN1 HDAC2 | 7.51e-07 | 1415 | 285 | 31 | 28515276 |
| Pubmed | DLG5 CAND1 SETX LIN7C MARK3 CLK4 KAT2A MRPS22 CNOT8 DHX8 GREB1L PNPLA6 ASCC2 AFDN LSM11 TAF10 IMMT SDHA ESYT1 SYNE1 RPP30 FARSB UFL1 IPO4 HARS2 GTF2H1 UTP4 EIF4A1 INTS9 EIF2AK2 EPB41L1 HDAC1 | 8.35e-07 | 1497 | 285 | 32 | 31527615 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 SETX MARK3 SEC24A PAK6 BCR TRIP12 LYST PTK2B MAST4 SYNE2 AFDN SIPA1L2 NEDD4L ESYT1 RGS12 VPS13D MTOR KIAA1217 NUP93 MAP2K2 EPB41L1 DOP1A | 8.50e-07 | 861 | 285 | 23 | 36931259 |
| Pubmed | CAND1 ERAP1 OBSCN FASTKD5 MRPS22 SERPINB6 RAD51 XRN2 MAP2K2 HDAC2 | 8.50e-07 | 159 | 285 | 10 | 31332168 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | TRIP12 PARP4 DOCK1 DDX60 IPO4 ECPAS EGFR MTOR TMPO PRKDC CAPRIN1 | 1.01e-06 | 202 | 285 | 11 | 33005030 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBA5 DLG5 CAND1 LIN7C ERAP1 PSMD8 MRPS22 SYNE2 PIP5K1A AFDN SCFD1 IMMT XRN2 SPTLC2 ESYT1 RRM2B IPO4 ECPAS APOBEC3B AKAP12 PTGR1 MTOR EIF4A1 TMPO HAGH PRKDC NUP93 CTNNB1 MMUT HDAC1 | 1.11e-06 | 1367 | 285 | 30 | 32687490 |
| Pubmed | CAND1 SEC24A PSMC3 HPRT1 AFDN SCFD1 USP15 ESYT1 NBEA IPO4 ECPAS AKAP12 RAB3GAP1 EIF4A1 TMPO PRKDC | 1.14e-06 | 449 | 285 | 16 | 31732153 | |
| Pubmed | UBA5 ABCC4 CAND1 PSMD3 TRIP12 HPRT1 USP15 IMMT DYNC1H1 RABGGTA SDHA USP47 SPTLC2 ESYT1 IPO4 ECPAS AKAP12 FHOD1 EIF4A1 PRKDC NUP93 MAP2K2 HDAC2 | 1.18e-06 | 878 | 285 | 23 | 37223481 | |
| Pubmed | CAND1 PSMC3 HPRT1 DKC1 IMMT DYNC1H1 SDHA ESYT1 SYNE1 EIF4A1 TMPO PRKDC NUP93 EIF2AK2 CAPRIN1 HDAC1 | 1.69e-06 | 463 | 285 | 16 | 34901782 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PSMC3 PSMD3 TRIP12 MRPS22 DHX8 STXBP1 HPRT1 SCFD1 DYNC1H1 XRN2 POLA1 RPP30 FARSB IPO4 RAB3GAP1 MTOR UTP4 EIF4A1 PRKDC EIF2AK2 | 1.79e-06 | 704 | 285 | 20 | 29955894 |
| Pubmed | 1.93e-06 | 101 | 285 | 8 | 26949739 | ||
| Pubmed | DLG5 RIPK1 MARK3 SEC24A HLCS PSMD3 AFDN IMMT DYNC1H1 SDHA DOCK1 ESYT1 FARSB ECPAS AKAP12 EGFR TMPO PRKDC EPB41L1 HDAC1 | 1.95e-06 | 708 | 285 | 20 | 39231216 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 20962258 | ||
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 24239178 | ||
| Pubmed | HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. | 2.16e-06 | 4 | 285 | 3 | 21423191 | |
| Pubmed | Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro. | 2.16e-06 | 4 | 285 | 3 | 26708311 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 27669650 | ||
| Pubmed | Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome†. | 2.16e-06 | 4 | 285 | 3 | 30590393 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 18188447 | ||
| Pubmed | Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. | 2.16e-06 | 4 | 285 | 3 | 23904166 | |
| Pubmed | Identification and characterization of a phosphoinositide phosphate kinase homolog. | 2.16e-06 | 4 | 285 | 3 | 14701839 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 20855874 | ||
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 21106820 | ||
| Pubmed | The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome. | 2.16e-06 | 4 | 285 | 3 | 23043085 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 27048565 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | FNBP1 ABCC4 CENPB MRPS22 CYRIA PNPLA6 SYPL1 AFDN PLCB4 MYRF BIN1 SPTLC2 SYNE1 RRM2B RGS12 AKAP12 GTPBP8 EGFR FHOD1 EPB41L1 | 2.46e-06 | 719 | 285 | 20 | 35337019 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO1D MYO1E BCR TRIP12 CNOT8 DHX8 PARP4 GRK2 PIP4K2A ASCC2 DKC1 PIP5K1A POLA1 DDX60 RPP30 AKAP12 SART1 UTP4 NAA30 CAPRIN1 | 2.73e-06 | 724 | 285 | 20 | 36232890 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CYP4F8 MYO1D MARK3 PSMC3 PSMD3 PSMD8 PAK6 MRPS22 CNOT8 CLK2 HPRT1 TONSL PIP5K1B AFDN USP15 UNC79 DYNC1H1 RAD51 UFL1 IPO4 ECPAS NXN EIF4A1 NUP93 CTNNB1 POLQ EIF2AK2 CAPRIN1 | 2.91e-06 | 1284 | 285 | 28 | 17353931 |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | MYO1E PSMD3 MRPS22 PTK2B KIF28P UNC79 SYNE1 ZFHX4 PKP3 TMPO MMUT HDAC1 HDAC2 | 2.93e-06 | 321 | 285 | 13 | 32098917 |
| Pubmed | HECW1 PSMD3 BCR LIN7A SERPINB6 STXBP1 GRK2 HPRT1 AFDN SIPA1L2 USP15 SDHA SHANK1 BIN1 NEDD4L GRIA1 NBEA SLC1A3 ADAM22 RAB3GAP1 CADPS KIAA1217 CTNNB1 CAPRIN1 EPB41L1 HDAC2 | 2.97e-06 | 1139 | 285 | 26 | 36417873 | |
| Pubmed | USP34 CAND1 PSMD8 TRIP12 STXBP1 SYNE2 SCN10A DYNC1H1 COX11 IPO4 RGS12 OTX1 PRKDC | 3.03e-06 | 322 | 285 | 13 | 26514267 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CAND1 LIN7C MARK3 ITGAV STXBP1 PIP5K1A BIN1 ESYT1 PIP5K1C AKAP12 TMPO CTNNB1 SNTB1 EPB41L1 | 3.33e-06 | 377 | 285 | 14 | 38117590 |
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 4.14e-06 | 14 | 285 | 4 | 28878358 | |
| Pubmed | USP34 MRPS22 SCFD1 USP15 ANAPC4 RPP30 IPO4 TIA1 ZFHX4 INTS9 NUP93 CTNNB1 | 4.27e-06 | 282 | 285 | 12 | 23667531 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | PSMD3 TRIP12 SACS SYNE2 BIN1 XRN2 NEDD4L ESYT1 NBEA IPO4 ECPAS CADPS TMPO CTNNB1 EIF2AK2 EPB41L1 | 4.28e-06 | 498 | 285 | 16 | 36634849 |
| Pubmed | CAND1 KAT2A SRCAP BCR TRIP12 TAF10 DOCK1 UBE2NL ARHGAP23 ECPAS SART1 GTF2H1 EIF4A1 MAP2K2 | 4.91e-06 | 390 | 285 | 14 | 17643375 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TRAF3IP2 MYO1E CENPB PSMC3 PSMD8 ITGAV BCR HPRT1 AFDN USP15 IMMT DYNC1H1 RPGRIP1 XRN2 ESYT1 IPO4 NXN AKAP12 WDR19 SART1 GTF2H1 MTOR TTC21B UGGT2 CTNNB1 CCDC144A HDAC1 HDAC2 | 4.96e-06 | 1321 | 285 | 28 | 27173435 |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 26655906 | ||
| Pubmed | Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis. | 5.38e-06 | 5 | 285 | 3 | 24240174 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 21471445 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 15713663 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 29478807 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 27045344 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 10403766 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 26638072 | ||
| Pubmed | The lipid kinase PIP5K1C regulates pain signaling and sensitization. | 5.38e-06 | 5 | 285 | 3 | 24853942 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 28030834 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 22046355 | ||
| Pubmed | Identification and mapping of human histone acetylation modifier gene homologues. | 5.38e-06 | 5 | 285 | 3 | 9722949 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 MYO1E CYTH3 OBSCN KAT2A SRCAP BCR LYST DUS1L PNPLA6 SIPA1L2 MYRF DYNC1H1 SDHA RAD51 PPP1R3B ESYT1 L1CAM SPATA20 PIP5K1C PKMYT1 PIKFYVE MTOR BTBD7 PRKDC | 5.41e-06 | 1105 | 285 | 25 | 35748872 |
| Pubmed | Iris phenotypes and pigment dispersion caused by genes influencing pigmentation. | 5.61e-06 | 15 | 285 | 4 | 18715234 | |
| Interaction | RAC1 interactions | FNBP1 PCYT1A DLG5 IL18 MYO1E MARK3 MCF2 PAK6 ITGAV BCR LIN7A PIP4K2A PIP5K1A PLCB4 SCFD1 IMMT DOCK1 BIN1 ARHGAP23 DOCK8 ESYT1 FARSB IPO4 PIP5K1C SLC1A3 AKAP12 PIKFYVE EGFR MTOR FHOD1 TMPO CTNNB1 MAP2K2 EIF2AK2 EPB41L1 | 1.83e-06 | 1063 | 279 | 35 | int:RAC1 |
| Interaction | RHOF interactions | PCYT1A DLG5 CAND1 MYO1D MYO1E MARK3 ITGAV PIP5K1A PLCB4 SCFD1 IMMT DOCK8 ESYT1 ECPAS PIP5K1C SLC1A3 AKAP12 PIKFYVE EGFR MTOR TMPO PRKDC CTNNB1 MAP2K2 EIF2AK2 EPB41L1 | 2.61e-06 | 673 | 279 | 26 | int:RHOF |
| Interaction | SNCA interactions | PSMC3 PSMD3 KAT2A TRIP12 MRPS22 PTK2B GRK2 SACS HPRT1 SYNE2 USP15 DYNC1H1 USP47 BIN1 XRN2 NEDD4L ESYT1 NBEA IPO4 ECPAS EGFR CADPS TMPO CTNNB1 EIF2AK2 EPB41L1 | 7.89e-06 | 716 | 279 | 26 | int:SNCA |
| Interaction | RAC2 interactions | PCYT1A MYO1E MARK3 ITGAV HPRT1 SYNE2 PIP5K1A PLCB4 SCFD1 IMMT DOCK1 ESYT1 FARSB UFL1 SLC1A3 ADAM22 AKAP12 VPS13D EGFR MTOR PKP3 FHOD1 TMPO CTNNB1 EPB41L1 | 8.28e-06 | 674 | 279 | 25 | int:RAC2 |
| Interaction | RHOJ interactions | FNBP1 DLG5 MYO1D MYO1E MARK3 PAK6 ITGAV GFOD1 PIP5K1A PLCB4 IMMT NEDD4L DOCK8 ESYT1 PIP5K1C SLC1A3 AKAP12 EGFR MTOR FHOD1 TMPO CTNNB1 SNTB1 EPB41L1 | 8.79e-06 | 633 | 279 | 24 | int:RHOJ |
| Interaction | RHOQ interactions | FNBP1 DLG5 MYO1D MYO1E MARK3 ITGAV GFOD1 PIP5K1A PLCB4 IMMT DOCK8 ESYT1 AKAP12 EGFR MTOR TMPO CTNNB1 SNTB1 EPB41L1 | 1.41e-05 | 442 | 279 | 19 | int:RHOQ |
| Interaction | SYNGAP1 interactions | CAND1 PTK2B SYNE2 SIPA1L2 DYNC1H1 SHANK1 DOCK1 GRIA1 NBEA SLC1A3 ADAM22 SART1 MTOR CTNNB1 EPB41L1 | 2.68e-05 | 307 | 279 | 15 | int:SYNGAP1 |
| Interaction | HNRNPC interactions | CAND1 PKDREJ DHX8 CLK2 RHOBTB2 DKC1 USP15 USP47 RAD51 XRN2 RBM45 UFL1 APOBEC3B NLRP3 SART1 EGFR TMPO PRKDC CTNNB1 EIF2AK2 LMBRD1 HDAC1 HDAC2 | 2.73e-05 | 634 | 279 | 23 | int:HNRNPC |
| Interaction | ANKEF1 interactions | 3.23e-05 | 14 | 279 | 4 | int:ANKEF1 | |
| Interaction | KCNA3 interactions | DLG5 RIPK1 MYO1D ABCA13 MARK3 SEC24A HLCS PSMD3 AFDN TRPM1 IMMT DYNC1H1 SDHA DOCK1 AFF2 NEDD4L ESYT1 FARSB ECPAS AKAP12 EGFR EIF4A1 TMPO PRKDC POLQ EPB41L1 DOP1A HDAC1 | 3.24e-05 | 871 | 279 | 28 | int:KCNA3 |
| Interaction | EIF2S1 interactions | UBA5 CAND1 IMMT SDHA DDX60 UFL1 TIA1 EGFR EIF4A1 PRKDC CTNNB1 MAP2K2 EIF2AK2 CAPRIN1 | 3.31e-05 | 276 | 279 | 14 | int:EIF2S1 |
| Interaction | PTEN interactions | FNBP1 PCYT1A CAND1 SETX MYO1D PSMD3 MRPS22 PTK2B SERPINB6 HPRT1 SCN10A ANAPC4 RAD51 BIN1 GPER1 RPP30 FARSB IPO4 AKAP12 PKMYT1 RAB3GAP1 CASD1 EGFR MTOR PRKDC CTNNB1 CCDC180 EIF2AK2 EPB41L1 | 3.96e-05 | 929 | 279 | 29 | int:PTEN |
| Interaction | RND1 interactions | FNBP1 DLG5 MARK3 ITGAV IMMT PCDHGA5 ESYT1 FARSB EGFR FHOD1 TMPO CTNNB1 EPB41L1 | 4.15e-05 | 246 | 279 | 13 | int:RND1 |
| Interaction | DLGAP1 interactions | CYTH3 SHANK1 NEDD4L SYNE1 GRIA1 NBEA ADAM22 KIAA1217 CTNNB1 CAPRIN1 EPB41L1 | 4.40e-05 | 180 | 279 | 11 | int:DLGAP1 |
| Interaction | MYH10 interactions | FNBP1 PSMC3 PSMD8 ZNF512B TDRD6 USP15 USP47 ESYT1 UFL1 ECPAS SART1 TMPO CTNNB1 CAPRIN1 HDAC1 HDAC2 | 4.42e-05 | 359 | 279 | 16 | int:MYH10 |
| Interaction | RHOB interactions | FNBP1 DLG5 MYO1D MYO1E MARK3 FASTKD5 ITGAV BCR HPRT1 PIP5K1A AFDN PLCB4 SCFD1 SIPA1L2 IMMT DOCK1 NEDD4L ESYT1 FARSB NBEA SLC1A3 AKAP12 SLC5A3 EGFR CTNNB1 SNTB1 EPB41L1 | 4.52e-05 | 840 | 279 | 27 | int:RHOB |
| Interaction | KCTD13 interactions | CAND1 MYO1D MYO1E MARK3 PSMC3 PSMD3 BCR MRPS22 PTK2B STXBP1 GRK2 PNPLA6 SACS PIP4K2A AFDN SIPA1L2 IMMT DYNC1H1 SDHA SHANK1 ADCY4 BIN1 NEDD4L ARHGAP23 DOCK8 SYNE1 L1CAM FARSB GRIA1 NBEA SLC1A3 ADAM22 CADPS KIAA1217 TMPO CTNNB1 CAPRIN1 EPB41L1 | 4.81e-05 | 1394 | 279 | 38 | int:KCTD13 |
| Interaction | MOB3C interactions | PCYT1A PSMC3 PSMD3 TRIP12 USP15 DYNC1H1 USP47 ESYT1 RPP30 UFL1 HARS2 TMPO PRKDC CTNNB1 HDAC1 HDAC2 | 5.21e-05 | 364 | 279 | 16 | int:MOB3C |
| Interaction | AICDA interactions | 6.75e-05 | 73 | 279 | 7 | int:AICDA | |
| Interaction | USP11 interactions | CAND1 SETX MYO1D CCND1 TRIP12 CNOT8 DKC1 USP15 IMMT DYNC1H1 SDHA SPTLC2 TIA1 EGFR MTOR UTP4 TMPO CTNNB1 HDAC1 HDAC2 | 6.76e-05 | 539 | 279 | 20 | int:USP11 |
| Interaction | PIP5KL1 interactions | 8.82e-05 | 7 | 279 | 3 | int:PIP5KL1 | |
| Interaction | TNIK interactions | PSMD8 BCR SYNE2 DYNC1H1 SHANK1 BIN1 NEDD4L SYNE1 GRIA1 NBEA SART1 EGFR KIAA1217 CTNNB1 CAPRIN1 HDAC2 | 8.90e-05 | 381 | 279 | 16 | int:TNIK |
| Interaction | ABCA1 interactions | 9.87e-05 | 54 | 279 | 6 | int:ABCA1 | |
| Interaction | SPAG9 interactions | FNBP1 PSMC3 PSMD3 BCR USP15 USP47 RRM2B REL PIKFYVE SART1 MAP2K2 HDAC1 HDAC2 | 9.91e-05 | 268 | 279 | 13 | int:SPAG9 |
| Interaction | CIT interactions | IL18 SETX RIPK1 MYO1E ESRP1 PSMC3 TRIP12 DHX8 FBXO3 SYNE2 DKC1 IMMT DYNC1H1 SDHA RAD51 XRN2 SYNE1 DDX60 RPP30 ECPAS SLC1A3 SART1 PKP3 UTP4 EIF4A1 TMPO INTS9 MYOM2 HAGH PRKDC NUP93 CTNNB1 SPAG17 CCDC180 EIF2AK2 CAPRIN1 HDAC1 HDAC2 | 1.10e-04 | 1450 | 279 | 38 | int:CIT |
| Interaction | NXF1 interactions | FNBP1 CAND1 MYO1E ERAP1 OBSCN PSMC3 PSMD3 CCND1 DHX8 GREB1L PNPLA6 CLK2 DKC1 PIP5K1A SCFD1 USP15 SDHA RAD51 BIN1 XRN2 POLA1 BTBD18 FARSB IPO4 ADAM22 HPS3 HARS2 GTPBP2 OTX2 EGFR MTOR DPY19L4 NUP93 CTNNB1 HDAC1 HDAC2 | 1.12e-04 | 1345 | 279 | 36 | int:NXF1 |
| Interaction | MTNR1B interactions | 1.12e-04 | 135 | 279 | 9 | int:MTNR1B | |
| Interaction | DUSP15 interactions | 1.13e-04 | 35 | 279 | 5 | int:DUSP15 | |
| Interaction | LRRC31 interactions | TRIP12 PARP4 DOCK1 DDX60 IPO4 ECPAS EGFR MTOR TMPO PRKDC CAPRIN1 | 1.41e-04 | 205 | 279 | 11 | int:LRRC31 |
| Interaction | RND2 interactions | FNBP1 DLG5 MARK3 ITGAV SYNE2 SCFD1 IMMT USP47 ESYT1 RAB3GAP1 EGFR PKP3 FHOD1 TMPO CTNNB1 MAP2K2 EPB41L1 | 1.47e-04 | 440 | 279 | 17 | int:RND2 |
| Interaction | C9orf78 interactions | PCYT1A PSMD3 FASTKD5 DHX8 ASCC2 SYPL1 PIP5K1A AFDN IMMT DYNC1H1 SDHA SPTLC2 ESYT1 IPO4 ECPAS RAB3GAP1 UTP4 TMPO NUP93 HDAC1 HDAC2 | 1.60e-04 | 620 | 279 | 21 | int:C9orf78 |
| Interaction | RUVBL1 interactions | FNBP1 CAND1 MYO1E PSMC3 PSMD3 SRCAP MRPS22 DKC1 USP15 USP47 DOCK8 UFL1 EGFR MTOR TMPO INTS9 PRKDC CTNNB1 HDAC1 HDAC2 | 1.61e-04 | 575 | 279 | 20 | int:RUVBL1 |
| GeneFamily | PDZ domain containing | DLG5 SYNPO2 LIN7C LIN7A MAST4 AFDN SIPA1L2 SHANK1 ARHGAP23 RGS12 SNTB1 | 9.29e-07 | 152 | 198 | 11 | 1220 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.25e-04 | 36 | 198 | 4 | 823 | |
| GeneFamily | Tudor domain containing | 6.94e-04 | 37 | 198 | 4 | 780 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 7.06e-04 | 4 | 198 | 2 | 1252 | |
| GeneFamily | CDC like kinases | 7.06e-04 | 4 | 198 | 2 | 480 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 7.06e-04 | 4 | 198 | 2 | 989 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.10e-03 | 19 | 198 | 3 | 832 | |
| GeneFamily | Tudor domain containing|Spindlin family | 1.17e-03 | 5 | 198 | 2 | 1089 | |
| Coexpression | GSE3039_NKT_CELL_VS_B2_BCELL_UP | ABCC4 SETX RIPK1 CYRIA MDP1 SERPINB6 PIP4K2A MPO HPS3 SLC5A3 PIKFYVE CD1D TIA1 NCKAP1L | 4.17e-08 | 200 | 283 | 14 | M6435 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP | MARK3 PSMD8 CCND1 TRIP12 BIN1 NEDD4L FARSB FIGN NXN APOBEC3B PIKFYVE RAB3GAP1 BTBD7 | 3.01e-07 | 200 | 283 | 13 | M9994 |
| Coexpression | GABRIELY_MIR21_TARGETS | FNBP1 USP34 LIN7C FBXO3 SYNE2 USP47 PPP1R3B NBEA FIGN SLC5A3 PLPP1 BTBD7 KLHL15 NAA30 CAPRIN1 | 6.73e-07 | 289 | 283 | 15 | M2196 |
| Coexpression | GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN | CLK4 HLCS ITGAV CNOT8 PLCB4 C5 USP47 LCP2 HPS3 CD1D LMBRD1 HDAC2 | 2.01e-06 | 200 | 283 | 12 | M4114 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | SETX HPS1 POC1B IMMT RAD51 DOCK1 L1CAM PHTF2 NBEA TIMP4 CCNB2 | 6.49e-06 | 187 | 283 | 11 | M6807 |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | SETX RIPK1 IDO1 SYNE2 TRPM1 AFF2 DDX60 RAB3GAP1 GTPBP8 PLPP1 EIF2AK2 | 1.17e-05 | 199 | 283 | 11 | M4635 |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | LIN7C RIPK1 ZNF512B PNPLA6 CLK2 AFDN USP47 DDX60 FHOD1 MAP2K2 HDAC1 | 1.17e-05 | 199 | 283 | 11 | M9964 |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | USP34 CYTH3 CLK4 SRCAP PIP4K2A PHTF2 FARSB CD1D TIA1 HDAC1 HDAC2 | 1.23e-05 | 200 | 283 | 11 | M3020 |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | CPA4 CYP4F8 CYP2J2 MC5R TNMD SERPINB6 PLA2G4F MYRF GPLD1 SPAG17 MUC3A | 1.48e-05 | 204 | 283 | 11 | MM17090 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | PSMC3 PSMD3 PSMD8 MRPS22 HPRT1 HPS1 DKC1 PIP5K1B TESC TRMT5 USP15 IMMT RPS6KL1 ATPAF1 SDHA NEDD4L ARHGAP23 SPTLC2 POLA1 RPP30 FARSB APOBEC3B PKMYT1 CCNB2 HAGH PRKDC NUP93 POLQ MAP2K2 CAPRIN1 HDAC2 | 2.13e-05 | 1271 | 283 | 31 | M39197 |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | TONSL IMMT THEMIS DPY19L1 ESYT1 DDX60 CASD1 TMPO CCNB1IP1 EIF2AK2 | 2.20e-05 | 175 | 283 | 10 | M6694 |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 2.25e-05 | 53 | 283 | 6 | M6303 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | FNBP1 SLC24A3 PAK6 LYST PTK2B CYRIA UNC79 BIN1 NEDD4L PCDHGC4 ARHGAP23 L1CAM MUC16 GRIA1 AKAP12 CADPS EPB41L1 | 4.08e-05 | 506 | 283 | 17 | M39067 |
| Coexpression | BILD_SRC_ONCOGENIC_SIGNATURE | 4.19e-05 | 59 | 283 | 6 | M116 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | FNBP1 IL18 ERAP1 PTK2B GRK2 PIP4K2A MPO THEMIS DOCK8 MAP3K8 DDX60 CASP1 REL LCP2 APOBEC3B NLRP3 HPS3 EIF2AK2 NCKAP1L | 4.50e-05 | 615 | 283 | 19 | MM3641 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | USP34 MYO1D DUS1L ME3 CLK2 SYNE2 SDHA USP47 BIN1 SYNE1 PIP5K1C RAB3GAP1 VPS13D MTOR INTS9 CTNNB1 SNTB1 NCKAP1L | 5.05e-05 | 567 | 283 | 18 | M16909 |
| Coexpression | SEIDEN_MET_SIGNALING | 5.62e-05 | 20 | 283 | 4 | M16468 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | ALDH8A1 ME3 PIGA RHOBTB2 NEDD4L DPY19L1 SYNE1 REL FHOD1 EPB41L1 | 6.01e-05 | 197 | 283 | 10 | M12824 |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN | 6.01e-05 | 197 | 283 | 10 | M3438 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | MC5R SYNE2 PIP5K1B DPY19L1 POLA1 SYNE1 PHTF2 APOBEC3B STS TMPO | 6.54e-05 | 199 | 283 | 10 | M9410 |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | FNBP1 CYTH3 TNMD SERPINB6 PIP4K2A PLCB4 GPLD1 SYNE1 CASP1 LBP | 6.54e-05 | 199 | 283 | 10 | M4331 |
| Coexpression | GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP | CLK4 SRCAP DUS1L PIP4K2A RABGGTA FARSB IPO4 TIA1 INTS9 SNTB1 | 6.82e-05 | 200 | 283 | 10 | M5821 |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 6.82e-05 | 200 | 283 | 10 | M5831 | |
| Coexpression | GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP | 6.82e-05 | 200 | 283 | 10 | M7282 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN | PCYT1A IL18 BFAR FBXO9 XRN2 CASP1 APOBEC3B AKAP12 INTS9 DOP1A | 6.82e-05 | 200 | 283 | 10 | M8781 |
| Coexpression | GSE30083_SP3_VS_SP4_THYMOCYTE_DN | TRAF3IP2 RIPK1 CCND1 SYNE2 C5 SCFD1 HS3ST3B1 RRM2B CASP1 UTP4 | 6.82e-05 | 200 | 283 | 10 | M5037 |
| Coexpression | KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP | CYP2J2 CYTH3 CLK4 SRCAP PIP4K2A SIPA1L2 NEDD4L IPO4 TIA1 HAGH | 6.82e-05 | 200 | 283 | 10 | M3012 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.38e-04 | 177 | 283 | 9 | M39245 | |
| Coexpression | DAIRKEE_CANCER_PRONE_RESPONSE_BPA | 2.22e-04 | 51 | 283 | 5 | M8655 | |
| Coexpression | PGF_UP.V1_DN | 2.35e-04 | 190 | 283 | 9 | M2673 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 2.57e-04 | 152 | 283 | 8 | M39239 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 2.64e-04 | 193 | 283 | 9 | M3484 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | USP34 PCYT1A IDO1 OBSCN MC5R PSMD3 CNOT8 GRK2 CLK2 HPS1 DKC1 PLCB4 SCFD1 IMMT GPLD1 AFF2 SPTLC2 POLA1 PHTF2 GRIA1 REL KATNA1 ADAM22 NLRP3 CD1D TMPO PRKDC SLC14A2 HDAC1 NCKAP1L | 2.67e-04 | 1394 | 283 | 30 | M9585 |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 2.72e-04 | 116 | 283 | 7 | M2379 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | DLG5 CAND1 SETX SLC24A3 PSMD8 BFAR FZD8 PARP4 CYRIA SACS SPIN2B USP15 IMMT WSCD1 CPA5 PPP1R3B RRM2B FARSB COX11 CCNB2 KIAA1217 CAPRIN1 SNTB1 PLCE1 | 2.72e-04 | 1009 | 283 | 24 | M157 |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH1_UP | 2.85e-04 | 195 | 283 | 9 | M5422 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 2.86e-04 | 117 | 283 | 7 | MM931 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN | 2.96e-04 | 196 | 283 | 9 | M9996 | |
| Coexpression | GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP | 3.07e-04 | 197 | 283 | 9 | M5858 | |
| Coexpression | GSE3982_MAST_CELL_VS_BASOPHIL_UP | 3.07e-04 | 197 | 283 | 9 | M5438 | |
| Coexpression | GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN | TRAF3IP2 ABCC4 IDO1 DNAJB13 TAF10 MGAM PKMYT1 MAP2K2 EIF2AK2 | 3.19e-04 | 198 | 283 | 9 | M3317 |
| Coexpression | GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP | 3.19e-04 | 198 | 283 | 9 | M8377 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP | 3.19e-04 | 198 | 283 | 9 | M8404 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN | 3.19e-04 | 198 | 283 | 9 | M5253 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_DN | 3.31e-04 | 199 | 283 | 9 | M4821 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | 3.31e-04 | 199 | 283 | 9 | M7498 | |
| Coexpression | GSE30083_SP2_VS_SP3_THYMOCYTE_UP | 3.31e-04 | 199 | 283 | 9 | M5031 | |
| Coexpression | GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 3.31e-04 | 199 | 283 | 9 | M7619 | |
| Coexpression | GSE3982_MAST_CELL_VS_DC_UP | 3.31e-04 | 199 | 283 | 9 | M5426 | |
| Coexpression | GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 3.31e-04 | 199 | 283 | 9 | M6926 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 3.43e-04 | 200 | 283 | 9 | M3378 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP | 3.43e-04 | 200 | 283 | 9 | M4626 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_2H_BMDC_UP | 3.43e-04 | 200 | 283 | 9 | M3937 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN | 3.43e-04 | 200 | 283 | 9 | M3971 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | PIP4K2A TESC HS3ST3B1 RABGGTA THEMIS SYNE1 RRM2B L1CAM VPS13D | 3.43e-04 | 200 | 283 | 9 | M7441 |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP | 3.43e-04 | 200 | 283 | 9 | M6437 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP | 3.43e-04 | 200 | 283 | 9 | M4021 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP | 3.43e-04 | 200 | 283 | 9 | M6597 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | CAND1 SETX SLC24A3 PSMD8 BFAR CYRIA SACS USP15 IMMT WSCD1 CPA5 PPP1R3B RRM2B SNTB1 | 3.45e-04 | 441 | 283 | 14 | M172 |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 3.45e-04 | 56 | 283 | 5 | M10332 | |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 3.45e-04 | 56 | 283 | 5 | MM648 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HECW1 ABCA13 OBSCN UNC79 OTOA MGAM MROH2A FIGN DNAH1 ZFHX4 MYOM2 SPAG17 PLCE1 | 2.03e-10 | 184 | 283 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HECW1 ABCA13 OBSCN UNC79 OTOA MGAM MROH2A FIGN DNAH1 ZFHX4 MYOM2 SPAG17 PLCE1 | 2.03e-10 | 184 | 283 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HECW1 ABCA13 OBSCN UNC79 OTOA MGAM MROH2A FIGN DNAH1 ZFHX4 MYOM2 SPAG17 PLCE1 | 2.03e-10 | 184 | 283 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ABCA13 LIN7A NTNG2 FBXO9 TESC MPO MGAM AFF2 SYNE1 FIGN POLQ RGL4 | 6.50e-09 | 200 | 283 | 12 | 5ee43386da8261d2e7602a152e6ba4338d844e08 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D MYO1E PIP5K1B HS3ST3B1 HS3ST3A1 DOCK8 SYNE1 PHTF2 NBEA AKAP12 | 7.74e-08 | 159 | 283 | 10 | 5ca96db4281abb5f646150ccf36adc66ab201c78 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D MYO1E MCF2 PIP5K1B HS3ST3B1 HS3ST3A1 DOCK8 SYNE1 PHTF2 NBEA | 1.45e-07 | 170 | 283 | 10 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO1D MYO1E MCF2 PIP5K1B HS3ST3B1 HS3ST3A1 DOCK8 SYNE1 PHTF2 NBEA | 1.45e-07 | 170 | 283 | 10 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SYNPO2 RSPH14 COL6A5 CFAP65 CFAP47 DNAH1 SPAG17 CCDC180 SLC14A2 LRRC36 | 2.11e-07 | 177 | 283 | 10 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RSPH14 COL6A5 CFAP65 CFAP47 DNAH1 CFAP74 SPAG17 CCDC180 SLC14A2 LRRC36 | 2.22e-07 | 178 | 283 | 10 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RSPH14 COL6A5 CFAP65 CFAP47 DNAH1 CFAP74 SPAG17 CCDC180 SLC14A2 LRRC36 | 2.22e-07 | 178 | 283 | 10 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RSPH14 ODAD1 COL6A5 CFAP65 LBP DNAH1 CFAP74 SPAG17 CCDC180 LRRC36 | 3.02e-07 | 184 | 283 | 10 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RSPH14 ODAD1 COL6A5 CFAP65 LBP DNAH1 CFAP74 SPAG17 CCDC180 LRRC36 | 3.02e-07 | 184 | 283 | 10 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RSPH14 ODAD1 COL6A5 CFAP65 LBP DNAH1 CFAP74 SPAG17 CCDC180 LRRC36 | 3.02e-07 | 184 | 283 | 10 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | RSPH14 ABCA13 ODAD1 CFAP65 DNAJB13 CFAP47 MUC16 CFAP74 SPAG17 CCDC180 | 4.92e-07 | 194 | 283 | 10 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | MYO1D MAST4 SYNE2 PLCB4 CFAP47 NEDD4L SYNE1 NBEA KIAA1217 SPAG17 | 5.16e-07 | 195 | 283 | 10 | fce0c29574bb7aab181b9c00feb42681e285d1f2 |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | MYO1D MAST4 SYNE2 PLCB4 CFAP47 NEDD4L SYNE1 NBEA KIAA1217 SPAG17 | 5.16e-07 | 195 | 283 | 10 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | USP34 SETX TRIP12 SYNE2 USP15 DYNC1H1 DOCK8 DDX60 REL EIF2AK2 | 6.50e-07 | 200 | 283 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SETX STXBP1 MAST4 SYNE2 AFDN PLCB4 SIPA1L2 ADCY4 SPTLC2 KIAA1217 | 6.50e-07 | 200 | 283 | 10 | a2b9d1cd291d17abddc3ee2e242121412c864b8b |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | DLG5 SETX SRCAP GFOD1 SYNE2 PIP4K2A SYNE1 DDX60 MYOM2 EIF2AK2 | 6.50e-07 | 200 | 283 | 10 | 2281debd86e5d92e8fe0397aec9ef670800f7471 |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.50e-07 | 200 | 283 | 10 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 175 | 283 | 9 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-06 | 177 | 283 | 9 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 177 | 283 | 9 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 177 | 283 | 9 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.84e-06 | 184 | 283 | 9 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.97e-06 | 185 | 283 | 9 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Ptgfr_(Postsubiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.07e-06 | 98 | 283 | 7 | 9865a9de11dea6db0b75dd04fee523cd2da44766 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-06 | 187 | 283 | 9 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-06 | 187 | 283 | 9 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.24e-06 | 187 | 283 | 9 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-06 | 188 | 283 | 9 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-06 | 188 | 283 | 9 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.39e-06 | 188 | 283 | 9 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-06 | 188 | 283 | 9 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-06 | 188 | 283 | 9 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-06 | 188 | 283 | 9 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.85e-06 | 191 | 283 | 9 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | TRAF3IP2 ABCC4 SLC24A3 MAST4 RHOBTB2 NBEA AKAP12 CADPS EPB41L1 | 3.85e-06 | 191 | 283 | 9 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.85e-06 | 191 | 283 | 9 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 191 | 283 | 9 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.02e-06 | 192 | 283 | 9 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 4.02e-06 | 192 | 283 | 9 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.02e-06 | 192 | 283 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CENPB CCND1 PIP4K2A SYNE1 MROH2A BTBD7 CTNNB1 CAPRIN1 NCKAP1L | 4.02e-06 | 192 | 283 | 9 | 1ccc47792edf9ee23501c8e2165d11271636b66a |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-06 | 193 | 283 | 9 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.20e-06 | 193 | 283 | 9 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.20e-06 | 193 | 283 | 9 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-06 | 194 | 283 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.38e-06 | 194 | 283 | 9 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCC4 ESRP1 MAST4 RHOBTB2 PIP5K1B PLA2G4F GPLD1 NEDD4L SYNE1 | 4.38e-06 | 194 | 283 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-06 | 194 | 283 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.56e-06 | 195 | 283 | 9 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.56e-06 | 195 | 283 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.56e-06 | 195 | 283 | 9 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-06 | 195 | 283 | 9 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.56e-06 | 195 | 283 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 195 | 283 | 9 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | ABCA13 MAST4 SYNE2 PLCB4 CFAP47 NEDD4L SYNE1 KIAA1217 SPAG17 | 4.76e-06 | 196 | 283 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | ABCA13 MAST4 SYNE2 PLCB4 CFAP47 NEDD4L SYNE1 KIAA1217 SPAG17 | 4.76e-06 | 196 | 283 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 4.76e-06 | 196 | 283 | 9 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.96e-06 | 197 | 283 | 9 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.96e-06 | 197 | 283 | 9 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | UBA5 MYO1E KIAA1958 MEF2B AFF2 NLRP3 CCNB2 KIAA1217 CCDC144A | 4.96e-06 | 197 | 283 | 9 | 2071526fe46de8359ea118ff78581eb4454aa55a |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 5.16e-06 | 198 | 283 | 9 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ESRP1 MAST4 RHOBTB2 KIAA1958 PIP5K1B NEDD4L EGFR KIAA1217 SNTB1 | 5.38e-06 | 199 | 283 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 283 | 9 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.60e-06 | 200 | 283 | 9 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 283 | 9 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.60e-06 | 200 | 283 | 9 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 5.60e-06 | 200 | 283 | 9 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.60e-06 | 200 | 283 | 9 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.60e-06 | 200 | 283 | 9 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 283 | 9 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.60e-06 | 200 | 283 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 5.60e-06 | 200 | 283 | 9 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | RSPH14 ODAD1 CFAP65 DNAJB13 CFAP47 DNAH1 CFAP74 SPAG17 CCDC180 | 5.60e-06 | 200 | 283 | 9 | 31d75c26055177d656df1fbb10b764cebd61e122 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 283 | 9 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | RSPH14 ODAD1 CFAP65 DNAJB13 CFAP47 DNAH1 CFAP74 SPAG17 CCDC180 | 5.60e-06 | 200 | 283 | 9 | e1dce91c6c531bb212002a14705e496d77ad3490 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 283 | 9 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.60e-06 | 200 | 283 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 283 | 9 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 8.28e-06 | 159 | 283 | 8 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-06 | 162 | 283 | 8 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 164 | 283 | 8 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 165 | 283 | 8 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.31e-05 | 122 | 283 | 7 | aca079f2f033cc1ac13c4ee02d490b6a514cbd5c | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.31e-05 | 122 | 283 | 7 | ac38130010f76648757eac700a8039f3960ddde3 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.31e-05 | 122 | 283 | 7 | 7ab0b63244116e74c5783c3293cf08224d094d0a | |
| ToppCell | Thalamus-Macroglia-CSF_related|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.31e-05 | 122 | 283 | 7 | eb944243424460bf5c66aced3ed7b7a1b6486ac7 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.31e-05 | 122 | 283 | 7 | 9b0d6b0a394560ff5aadcd3b21519c2393e6def8 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.35e-05 | 170 | 283 | 8 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-05 | 172 | 283 | 8 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 173 | 283 | 8 | a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 173 | 283 | 8 | e3e3a67a5a93ef4475224a256d45ae24526383cc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 175 | 283 | 8 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.66e-05 | 175 | 283 | 8 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 127 | 283 | 7 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 176 | 283 | 8 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.79e-05 | 128 | 283 | 7 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-05 | 177 | 283 | 8 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| Drug | dimethyl phthalate | TRAF3IP2 ABCC4 SETX MARK3 SLC24A3 CCND1 SERPINB6 PNPLA6 FBXO3 PIP5K1B DYNC1H1 RAD51 MGAM BIN1 RRM2B GRIA1 FIGN SLC1A3 RGS12 PTGR1 CADPS CCNB2 CTNNB1 EIF2AK2 HDAC1 | 3.36e-06 | 714 | 282 | 25 | ctd:C024629 |
| Drug | manganese chloride | IL18 ERAP1 ITGAV ABCA9 ME3 PTK2B TRPM1 USP15 SDHA MPO NEDD4L SLC1A3 GTF2H1 EGFR PTGR1 MTOR CCNB2 CTNNB1 PLCE1 | 4.67e-06 | 456 | 282 | 19 | ctd:C025340 |
| Drug | CID11987713 | CCND1 BCR TONSL SPIN2A SPIN2B DYNC1H1 CASP1 REL NBEA TIA1 EGFR CTNNB1 | 4.73e-06 | 190 | 282 | 12 | CID011987713 |
| Drug | Go6976 | MARK3 CCND1 PTK2B GRK2 TONSL GPLD1 PIKFYVE STS PLPP1 EGFR PRKDC MAP2K2 | 4.73e-06 | 190 | 282 | 12 | CID000003501 |
| Drug | 4-hydroxynonenal | IL18 MARK3 PSMC3 PSMD8 CCND1 TONSL PLCB4 MPO ADCY4 CASP1 COX11 REL SLC1A3 EGFR PTGR1 MTOR PRKDC CTNNB1 PLCE1 | 7.41e-06 | 471 | 282 | 19 | CID000001693 |
| Drug | bosutinib | 1.23e-05 | 42 | 282 | 6 | CID005328940 | |
| Drug | saracatinib | 1.82e-05 | 27 | 282 | 5 | CID010302451 | |
| Drug | erionite | 1.85e-05 | 5 | 282 | 3 | ctd:C083174 | |
| Drug | geldanamicin | RIPK1 CCND1 BCR PTK2B GRK2 HPRT1 TONSL POLA1 CASP1 LBP PIKFYVE EGFR MTOR MYOM2 MAP2K2 EIF2AK2 | 1.87e-05 | 373 | 282 | 16 | CID000003460 |
| Drug | pyrophosphate | GLYAT PCYT1A MYO1D MYO1E HLCS HPRT1 AFDN PLCB4 TAF10 IMMT SDHA ANAPC4 MGAM UBE2NL ADCY4 POLA1 FARSB HARS2 GTF2H1 PLPP1 POLQ PLCE1 | 2.44e-05 | 654 | 282 | 22 | CID000001023 |
| Drug | 1-Butanol | 2.56e-05 | 70 | 282 | 7 | ctd:D020001 | |
| Drug | H2O2 | IL18 IDO1 PSMC3 CCND1 TNMD PTK2B GRK2 HPRT1 TONSL PIP5K1B PLCB4 IMMT MPO GPLD1 ADCY4 PPP1R3B POLA1 RRM2B CASP1 COX11 REL SPATA20 PIKFYVE GTF2H1 PLPP1 EGFR MTOR TMPO CTNNB1 POLQ MAP2K2 PLCE1 | 2.95e-05 | 1183 | 282 | 32 | CID000000784 |
| Drug | AC1Q6S3U | 3.05e-05 | 159 | 282 | 10 | CID000000689 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | MYO1D ERAP1 GRK2 MAST4 RHOBTB2 MYRF DDX60 AKAP12 WDR19 TIA1 PKP3 | 3.22e-05 | 194 | 282 | 11 | 1239_UP |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; HL60; HT_HG-U133A | 3.22e-05 | 194 | 282 | 11 | 2206_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | ERAP1 SEC24A BCR STXBP1 FBXO9 RHOBTB2 HPS1 RAB3GAP1 VPS13D TIA1 INTS9 | 3.22e-05 | 194 | 282 | 11 | 1264_DN |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A | FNBP1 RSPH14 HLCS LIN7A TESC HS3ST3A1 GPER1 PHTF2 ADAM22 RGS12 VPS13D | 3.54e-05 | 196 | 282 | 11 | 5394_DN |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A | PCYT1A SEC24A KAT2A LYST LIN7A ZNF512B HPS1 PLCB4 PHTF2 PIP5K1C BTBD7 | 3.71e-05 | 197 | 282 | 11 | 3070_DN |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | FNBP1 HECW1 NPAS3 RHOBTB2 BIN1 AFF2 MAP3K8 ADAM22 RGS12 VPS13D DNAH17 | 3.71e-05 | 197 | 282 | 11 | 7358_UP |
| Drug | splitomicin; Down 200; 20uM; PC3; HG-U133A | SETX HPS1 DOCK1 GPLD1 NEDD4L UFL1 ECPAS ADAM22 PKMYT1 SNTB1 EPB41L1 | 3.88e-05 | 198 | 282 | 11 | 661_DN |
| Drug | AC1OAGKB | CYTH3 CCND1 BCR PTK2B GRK2 RAD51 DOCK1 PIKFYVE EGFR MTOR CTNNB1 | 3.88e-05 | 198 | 282 | 11 | CID006857406 |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | GLYAT PTK2B CYRIA GRK2 SCN10A RAD51 GPER1 SPTLC2 DDX60 SLC5A3 DOP1A | 4.07e-05 | 199 | 282 | 11 | 4973_UP |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | RSPH14 HLCS SRCAP MAST4 C5 HS3ST3A1 BIN1 BTBD7 DNAH17 CTNNB1 EPB41L1 | 4.07e-05 | 199 | 282 | 11 | 3860_DN |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | TRAF3IP2 USP34 ABCC4 SLC24A3 FBXO9 MAST4 HPS1 WDR19 MTOR BTBD7 EPB41L1 | 4.07e-05 | 199 | 282 | 11 | 7439_UP |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | GLYAT HECW1 GREB1L GRK2 WSCD1 SPTLC2 ADAM22 VPS13D STS ZFHX4 PLCE1 | 4.26e-05 | 200 | 282 | 11 | 2272_UP |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | HLCS SRCAP HPS1 C5 GPLD1 ADAM22 RGS12 SLC5A3 WDR19 STS ZMYM6 | 4.26e-05 | 200 | 282 | 11 | 5264_DN |
| Drug | ERK inhibitor | IL18 CCND1 PTK2B TONSL AKAP12 PIKFYVE EGFR TIMP4 MTOR MAP2K2 | 4.41e-05 | 166 | 282 | 10 | CID001249835 |
| Drug | methyl ethyl ketone | IL18 CYP2J2 MARK3 CCND1 ITGAV BCR PTK2B GRK2 TONSL SCFD1 GPLD1 SPTLC2 MAP3K8 EGFR MTOR CCNB2 FHOD1 CTNNB1 SPAG17 MAP2K2 | 4.82e-05 | 587 | 282 | 20 | CID000006569 |
| Drug | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine | 5.83e-05 | 34 | 282 | 5 | ctd:C549066 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | TRAF3IP2 FZD8 PARP4 GRK2 GPER1 SLC5A3 CASD1 PKP3 TMPO CAPRIN1 | 5.96e-05 | 172 | 282 | 10 | 4344_DN |
| Drug | Lithium | PSMD8 CCND1 PTK2B PARP4 HPRT1 MAP3K8 GRIA1 REL MTOR CCNB2 CTNNB1 SLC14A2 | 6.18e-05 | 246 | 282 | 12 | ctd:D008094 |
| Drug | benzoquinone | BCR HPRT1 TAF10 MPO POLA1 SYNE1 CASP1 LBP SLC1A3 MTOR EIF2AK2 | 6.34e-05 | 209 | 282 | 11 | CID000004650 |
| Drug | 3-(2-(dimethylamino)isopropoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dione | 6.34e-05 | 7 | 282 | 3 | ctd:C560905 | |
| Drug | trovafloxacin | GLYAT IL18 CCND1 FBXO9 PIP5K1A GPLD1 NEDD4L MAP3K8 REL CASD1 STS EGFR CCNB2 TMPO CAPRIN1 | 6.66e-05 | 371 | 282 | 15 | ctd:C080163 |
| Drug | ethyl methanesulfonate | 7.36e-05 | 111 | 282 | 8 | CID000006113 | |
| Disease | Intellectual Disability | UBA5 NTNG2 SACS RHOBTB2 USP27X DYNC1H1 DOCK8 SYNE1 RRM2B FARSB GRIA1 NBEA GTPBP2 MTOR KLHL15 ZMYM6 EPB41L1 | 1.04e-06 | 447 | 272 | 17 | C3714756 |
| Disease | cervical cancer | 1.43e-05 | 34 | 272 | 5 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 1.66e-05 | 35 | 272 | 5 | C0007873 | |
| Disease | Schizophrenia | IL18 ABCA13 MC5R NPAS3 FASTKD5 CCND1 CFAP65 NTNG2 STXBP1 PIP4K2A TRPM1 SDHA SHANK1 LYRM4 GRIA1 SLC1A3 RGS12 MTOR HAGH CTNNB1 HDAC1 HDAC2 | 2.69e-05 | 883 | 272 | 22 | C0036341 |
| Disease | Cardiomyopathy, Familial Idiopathic | 9.68e-05 | 50 | 272 | 5 | C1449563 | |
| Disease | Lymphoma, Lymphocytic, Intermediate | 1.21e-04 | 11 | 272 | 3 | C0751958 | |
| Disease | Squamous cell carcinoma | 1.57e-04 | 124 | 272 | 7 | C0007137 | |
| Disease | social communication impairment | 2.07e-04 | 32 | 272 | 4 | EFO_0005427 | |
| Disease | Colorectal Carcinoma | ABCC4 ABCA13 OBSCN CCND1 PAK6 ABCA9 SACS ANAPC4 SHANK1 MPO SYNE1 NXN HPS3 AKAP12 EGFR CTNNB1 SPAG17 | 3.10e-04 | 702 | 272 | 17 | C0009402 |
| Disease | Opioid use measurement | 3.25e-04 | 15 | 272 | 3 | EFO_0009937 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 3.25e-04 | 15 | 272 | 3 | DOID:2223 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | IL18 ERAP1 BCR DUS1L LIN7A FZD8 CYRIA FBXO9 SPIN2A PPP1R3B MAP3K8 CASP1 NBEA LBP LCP2 CCNB2 HAGH NCKAP1L | 3.37e-04 | 774 | 272 | 18 | C0023893 |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 3.97e-04 | 16 | 272 | 3 | C0334634 | |
| Disease | Inherited neuropathies | 4.97e-04 | 40 | 272 | 4 | C0598589 | |
| Disease | age-related macular degeneration, cataract, glaucoma | 5.02e-04 | 4 | 272 | 2 | EFO_0001365, MONDO_0005041, MONDO_0005129 | |
| Disease | Malignant neoplasm of cecum | 5.02e-04 | 4 | 272 | 2 | C0153437 | |
| Disease | Jeune thoracic dystrophy | 5.02e-04 | 4 | 272 | 2 | cv:C0265275 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 5.02e-04 | 4 | 272 | 2 | cv:CN293514 | |
| Disease | bronchiolo-alveolar adenocarcinoma (is_marker_for) | 5.02e-04 | 4 | 272 | 2 | DOID:4926 (is_marker_for) | |
| Disease | Cecal Neoplasms | 5.02e-04 | 4 | 272 | 2 | C0007528 | |
| Disease | Endometrioma | 7.65e-04 | 161 | 272 | 7 | C0269102 | |
| Disease | Endometriosis | 7.65e-04 | 161 | 272 | 7 | C0014175 | |
| Disease | calcium measurement | CPA4 ABCC4 CCND1 ABCA9 FBXO3 HPRT1 SYNE2 HPS1 PIP5K1A PIP5K1B EXOC3L2 PHTF2 RGS12 POLQ PLCE1 | 7.98e-04 | 628 | 272 | 15 | EFO_0004838 |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 8.31e-04 | 5 | 272 | 2 | C0410190 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 8.31e-04 | 5 | 272 | 2 | C1450051 | |
| Disease | prostaglandin reductase 1 measurement | 8.31e-04 | 5 | 272 | 2 | EFO_0801932 | |
| Disease | status epilepticus (implicated_via_orthology) | 9.11e-04 | 21 | 272 | 3 | DOID:1824 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | CAND1 TRIP12 PIP4K2A PIP5K1A PIP5K1B PIP5K1C MTOR CTNNB1 MAP2K2 | 9.11e-04 | 268 | 272 | 9 | DOID:162 (implicated_via_orthology) |
| Disease | Cardiomyopathy, Dilated | 9.99e-04 | 48 | 272 | 4 | C0007193 | |
| Disease | asthma (is_marker_for) | 1.14e-03 | 126 | 272 | 6 | DOID:2841 (is_marker_for) | |
| Disease | JT interval, response to sulfonylurea | 1.20e-03 | 23 | 272 | 3 | EFO_0007885, EFO_0007922 | |
| Disease | Rheumatoid Arthritis | 1.20e-03 | 174 | 272 | 7 | C0003873 | |
| Disease | Malignant Neoplasms | 1.23e-03 | 128 | 272 | 6 | C0006826 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.24e-03 | 6 | 272 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.24e-03 | 6 | 272 | 2 | C0410189 | |
| Disease | response to antineoplastic agent, response to doxorubicin | 1.24e-03 | 6 | 272 | 2 | GO_0097327, GO_1902520 | |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 1.24e-03 | 6 | 272 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | pulmonary emphysema (biomarker_via_orthology) | 1.24e-03 | 6 | 272 | 2 | DOID:9675 (biomarker_via_orthology) | |
| Disease | Cancer of Head | 1.36e-03 | 24 | 272 | 3 | C0751177 | |
| Disease | disease free survival, response to mepolizumab | 1.36e-03 | 24 | 272 | 3 | EFO_0000409, EFO_0008459 | |
| Disease | Head Neoplasms | 1.36e-03 | 24 | 272 | 3 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 1.36e-03 | 24 | 272 | 3 | C0887900 | |
| Disease | Neck Neoplasms | 1.53e-03 | 25 | 272 | 3 | C0027533 | |
| Disease | Cancer of Neck | 1.53e-03 | 25 | 272 | 3 | C0746787 | |
| Disease | Neurodevelopmental Disorders | 1.72e-03 | 93 | 272 | 5 | C1535926 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.72e-03 | 7 | 272 | 2 | C0751337 | |
| Disease | invasive lobular carcinoma (is_marker_for) | 1.72e-03 | 7 | 272 | 2 | DOID:3457 (is_marker_for) | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.72e-03 | 7 | 272 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | acute kidney failure (implicated_via_orthology) | 1.92e-03 | 27 | 272 | 3 | DOID:3021 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 1.98e-03 | 96 | 272 | 5 | C1319315 | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 2.14e-03 | 28 | 272 | 3 | DOID:3083 (biomarker_via_orthology) | |
| Disease | melanoma | 2.23e-03 | 248 | 272 | 8 | C0025202 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 2.29e-03 | 8 | 272 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | urticaria (is_implicated_in) | 2.29e-03 | 8 | 272 | 2 | DOID:1555 (is_implicated_in) | |
| Disease | Attached earlobe | 2.29e-03 | 8 | 272 | 2 | HP_0009907 | |
| Disease | Retinal Dystrophies | 2.29e-03 | 8 | 272 | 2 | C0854723 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.32e-03 | 145 | 272 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 2.37e-03 | 100 | 272 | 5 | C0010606 | |
| Disease | Strabismus | 2.37e-03 | 29 | 272 | 3 | HP_0000486 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.44e-03 | 61 | 272 | 4 | DOID:3587 (is_marker_for) | |
| Disease | cutaneous melanoma, hair color | 2.59e-03 | 62 | 272 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 2.62e-03 | 30 | 272 | 3 | C1868672 | |
| Disease | transitional cell carcinoma (is_marker_for) | 2.75e-03 | 63 | 272 | 4 | DOID:2671 (is_marker_for) | |
| Disease | obsessive-compulsive symptom measurement | 2.88e-03 | 31 | 272 | 3 | EFO_0007802 | |
| Disease | bacterial pneumonia (is_marker_for) | 2.92e-03 | 9 | 272 | 2 | DOID:874 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.93e-03 | 152 | 272 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication | 3.15e-03 | 32 | 272 | 3 | C0001969 | |
| Disease | Squamous cell carcinoma of lung | 3.15e-03 | 32 | 272 | 3 | C0149782 | |
| Disease | Dupuytren Contracture | 3.31e-03 | 108 | 272 | 5 | EFO_0004229 | |
| Disease | Head and Neck Neoplasms | 3.45e-03 | 33 | 272 | 3 | C0018671 | |
| Disease | retinal degeneration (implicated_via_orthology) | 3.45e-03 | 33 | 272 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | Status Epilepticus | 3.62e-03 | 68 | 272 | 4 | C0038220 | |
| Disease | alopecia areata (is_marker_for) | 3.63e-03 | 10 | 272 | 2 | DOID:986 (is_marker_for) | |
| Disease | primary biliary cholangitis (is_implicated_in) | 3.63e-03 | 10 | 272 | 2 | DOID:12236 (is_implicated_in) | |
| Disease | linguistic error measurement, specific language impairment | 3.63e-03 | 10 | 272 | 2 | EFO_0007798, EFO_1001510 | |
| Disease | nephritis (implicated_via_orthology) | 3.63e-03 | 10 | 272 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | Hermanski-Pudlak Syndrome | 3.63e-03 | 10 | 272 | 2 | C0079504 | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 3.63e-03 | 10 | 272 | 2 | EFO_0020778 | |
| Disease | Hermansky-Pudlak syndrome | 3.63e-03 | 10 | 272 | 2 | cv:C0079504 | |
| Disease | renal hypertension (biomarker_via_orthology) | 3.63e-03 | 10 | 272 | 2 | DOID:1073 (biomarker_via_orthology) | |
| Disease | neutrophil count, eosinophil count | 3.75e-03 | 213 | 272 | 7 | EFO_0004833, EFO_0004842 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 3.75e-03 | 34 | 272 | 3 | DOID:9952 (is_marker_for) | |
| Disease | LDL peak particle diameter measurement, total fat intake measurement | 3.75e-03 | 34 | 272 | 3 | EFO_0007677, EFO_0007678 | |
| Disease | Kartagener Syndrome | 4.08e-03 | 35 | 272 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 4.08e-03 | 35 | 272 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 4.08e-03 | 35 | 272 | 3 | C4317124 | |
| Disease | epilepsy (implicated_via_orthology) | 4.13e-03 | 163 | 272 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | family history of Alzheimer’s disease | 4.23e-03 | 71 | 272 | 4 | EFO_0009268 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 4.41e-03 | 11 | 272 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Jeune thoracic dystrophy | 4.41e-03 | 11 | 272 | 2 | C0265275 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 4.41e-03 | 11 | 272 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | chemotherapy-induced alopecia, response to antimicrotubule agent | 4.41e-03 | 11 | 272 | 2 | EFO_0005260, EFO_0005400 | |
| Disease | Primary ciliary dyskinesia | 4.42e-03 | 36 | 272 | 3 | cv:C0008780 | |
| Disease | Adenocarcinoma | 4.48e-03 | 116 | 272 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 4.48e-03 | 116 | 272 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.48e-03 | 116 | 272 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.48e-03 | 116 | 272 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 4.48e-03 | 116 | 272 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 4.48e-03 | 116 | 272 | 5 | C0205641 | |
| Disease | pentachlorophenol measurement | 4.67e-03 | 73 | 272 | 4 | EFO_0022071 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GTFKRELLLAEEYPM | 51 | Q5JXB2 | |
| TAEQPYFIEAREKMA | 681 | Q7Z4L5 | |
| AVLDYVMTRPDLDKT | 171 | Q7L211 | |
| SRLAAEVYKDMPETS | 196 | P55196 | |
| EVYKDMPETSFTRTI | 201 | P55196 | |
| AVREMLPDTYISKTI | 111 | Q2M3D2 | |
| TRYKFVIPEVLSEMK | 621 | Q5W0A0 | |
| YMEKLLAETVAPAVR | 156 | Q9BSJ8 | |
| YFMLPTVITDIKDES | 371 | Q9H2A2 | |
| LYSFLPEVTRMARKF | 241 | Q9UJX5 | |
| PAETRDFIDAYLKEM | 271 | P51589 | |
| KEILRYLMDPDTFTF | 186 | Q9UH17 | |
| YIPLTDLSFQMVDEL | 756 | P11274 | |
| VVPLSEYDAVEREKM | 846 | Q02952 | |
| IESMLEYEPAKRLTL | 456 | P49760 | |
| ERFSSLMVYKLPVED | 1546 | Q8IUA7 | |
| KSPYTMYSETVELLR | 1121 | P51816 | |
| SFYEAAIPEMESAIK | 281 | Q9H1I8 | |
| VDYDSDMPRKITEVL | 146 | Q9BX10 | |
| ISENPLITLREFMKY | 301 | Q9P0K1 | |
| FPEIDKTVRYAQMLE | 151 | Q6P1R4 | |
| YFTELILRPIEMSDE | 1521 | Q86UQ4 | |
| EERTKKEMIDFPYSF | 2866 | Q86UQ4 | |
| EMEKEYRLSAIPAFK | 571 | Q8NFM4 | |
| MVFYSDEKERVIPLL | 2051 | Q5JWR5 | |
| AMNYLDRFLSLEPVK | 81 | P24385 | |
| FALDTEYMVLELSEP | 181 | Q6Q4G3 | |
| AEVIEKTSYLMRPEV | 286 | Q9P1Z9 | |
| LDEFYKLVDPERDMS | 186 | Q14444 | |
| EPSIRSVMQKYLEDR | 36 | P25098 | |
| PDIDKLDVATMTEYL | 151 | Q6NXG1 | |
| LLMLYTRKFESTDPR | 531 | Q8N1F7 | |
| DSRPAMAIFELLDYI | 311 | P36507 | |
| IFETYEKIPLLMDFD | 681 | Q09MP3 | |
| PQRMYSVLTKEDFRL | 956 | Q15042 | |
| TRIFVMIPKSYTEED | 121 | Q8IUH3 | |
| MIPKSYTEEDLREKF | 126 | Q8IUH3 | |
| KAMYIDTEGTFRPER | 156 | Q06609 | |
| AMSYRRAEVLALPFK | 496 | Q9NV88 | |
| RRYEKIEIMPELADS | 511 | Q9NV88 | |
| YEVIRFPIDLKTMTE | 766 | Q92830 | |
| IRYSMPEELDKGSFV | 31 | Q9Y5G8 | |
| RDTKETTAYMPVDFE | 526 | Q17RG1 | |
| SVMAFDRYKAIINPL | 116 | Q8NH69 | |
| TKQLDMVYDITPELA | 291 | Q7RTW8 | |
| LFAPLVVRYVDLMES | 976 | Q9ULU8 | |
| SFLTIELRDVSPYMD | 4011 | Q8WXI7 | |
| RISKSDFYEIMRAQP | 606 | Q8IY17 | |
| KVMLETPEYRSRFTS | 231 | Q9H0Q0 | |
| AAVLFRMSEDKPQDY | 656 | P35222 | |
| SKPEEIDESLRRYFM | 631 | Q5HY92 | |
| MLVTKAVVYRETDPS | 856 | Q9H4G0 | |
| KPLTYENMDVLFSFR | 141 | P14902 | |
| YFSDSPVQAMKRLRD | 601 | Q9NQU5 | |
| YMEIDAFVLLPSSSK | 361 | P18428 | |
| LEEMDTFLDTYTLPR | 426 | O00370 | |
| ITMEKTPSYFVTREA | 196 | Q9Y662 | |
| MALTDVDETYRKPVL | 196 | P83369 | |
| VRYTPKVLEEMEARF | 186 | O14910 | |
| VRYTPKVLEEMESRF | 171 | Q9NUP9 | |
| MARLPKLAVFDLDYT | 1 | Q86V88 | |
| DYIKFLRSIRPDNMS | 71 | Q13547 | |
| EFTYNPFMRVREKTV | 266 | Q16775 | |
| ILLSLFEEEIMSYVP | 1171 | Q76N89 | |
| SALLPVDIFLVSYMK | 61 | Q9NUN5 | |
| PVDKQDAYRMLSRLS | 101 | O95671 | |
| EVSMYSREEPLQLKL | 866 | Q6ZU64 | |
| DYMERQLDFTLSPKF | 1281 | O43451 | |
| IDYMERQLDFTLSPK | 2176 | O43451 | |
| RILYMAAETAKELTP | 131 | Q6IB77 | |
| TRESIPEDLYQKFMA | 221 | P50747 | |
| LILNEMPKAEYSSLF | 16 | Q8IY21 | |
| DMRVPFSELKDIKAY | 81 | Q8WXQ8 | |
| VSTRHEMLPEFYKTV | 361 | Q86VP6 | |
| KEEMRELAALFYSVV | 706 | Q5VYK3 | |
| QMTEDVYFPKDLRGT | 276 | P41279 | |
| PAQIREMFDDVSYDK | 426 | Q9NZ08 | |
| FTYRIRIEMSKDALP | 306 | Q9UK99 | |
| LSPKYIKMFVLDEAD | 171 | P60842 | |
| IEVDFSKPYVRVTME | 51 | P49585 | |
| PEKMTREGYQVSFLD | 266 | Q1X8D7 | |
| LFIIKTERSLHEPMY | 51 | Q8NGK0 | |
| SIVVDYLVLLEMPFS | 3081 | Q02505 | |
| MELLSYFKQPVAATR | 96 | P05164 | |
| SKPERDVLMQDFYVV | 46 | O14986 | |
| DFMEKETPLRYTKTL | 396 | Q2PZI1 | |
| IPSKYVMDQEFSRRL | 1651 | Q8TDM6 | |
| LEESAMLRYAIAFPL | 556 | P55160 | |
| EKTIPYSDKLFEMVL | 76 | Q16891 | |
| RPMKDETFGEYRSLE | 1166 | P32004 | |
| ITMEKTPSYFVTREA | 211 | Q9Y663 | |
| ERDILKEMFPYEAST | 341 | P42167 | |
| MASATEDPVLERYFK | 1 | Q8TC44 | |
| ECTDIKILPYRSMEL | 51 | Q9H3R1 | |
| GPLDREAKSSYDIMV | 411 | Q9Y5F7 | |
| ELIAKEDVDFLPYMS | 1196 | Q9UKK3 | |
| DYSLEAPFEVLKMTE | 706 | Q68DD2 | |
| RAPEDFVDMVETYLK | 171 | Q8N3Z3 | |
| TFEKMVNTLLERYPR | 886 | Q9C091 | |
| YPMSREELLSQVEKL | 476 | Q96M63 | |
| STKPERDVLMQDFYV | 101 | Q99755 | |
| TLYFLPREMKIDLNT | 386 | P09884 | |
| DMDRVLLKYTEYSEP | 61 | Q02080 | |
| KASVIMVDELLSAYP | 306 | Q9HC58 | |
| LFAKTRYPDIFMREE | 56 | P32242 | |
| RSIPMTVDFIRLKSY | 91 | P00492 | |
| VSFEKLVYVRMSLDD | 151 | Q16821 | |
| VLPSDKFKDYLETMA | 7821 | Q5VST9 | |
| SVMAFDRYIAISKPL | 116 | Q8NGE8 | |
| KRRLEEDDMYSVLPE | 36 | O15439 | |
| RPLEKFVTYFTRMEQ | 441 | Q8IZJ4 | |
| LRKLVDFLYTSEMEV | 86 | B2RXH4 | |
| FYATEDDRFILKQMP | 1866 | Q9Y2I7 | |
| VSTFLIDMERFKYPE | 296 | Q9H461 | |
| DKLSRMVKEFQPYLD | 1011 | Q9P2D7 | |
| EKDIDLTRMEYIPVA | 3436 | Q9P2D7 | |
| IEFSKMARDPQRYLV | 966 | P00533 | |
| FAMVKRYLTSFPIDD | 551 | P07199 | |
| YSSLISEIHRKMPEF | 451 | Q7L8L6 | |
| MSRPDFLSYLSFEKL | 166 | Q96M94 | |
| KSYVNTMDLERDEPL | 6 | Q9NZS9 | |
| PVYEDLLSENRKMIT | 211 | Q96PB1 | |
| EIYPIMDKSSRTRLA | 151 | P29466 | |
| EVLMSLYDPVESKFI | 241 | Q14185 | |
| ETELRKATIPIFFDM | 1096 | Q14185 | |
| ILYDTVKMREFQEDP | 1606 | Q8NF50 | |
| LLLASKYEEMFSPNI | 216 | O95067 | |
| VAPRYSVMLELFDAE | 541 | Q9UFH2 | |
| RFDLPDMKETKYTVD | 246 | P19525 | |
| DIEFEDYTQPMKRTV | 281 | Q96RU3 | |
| EFAKMLRLSYPLELQ | 101 | P15813 | |
| MQLVPDIEFKITYTR | 121 | Q9UK97 | |
| LRPNEFKYMSVIAEL | 296 | Q5TC12 | |
| DPRMIKVDLITLSYT | 246 | Q9Y6N1 | |
| REVKYFSFPGELLMR | 76 | P43003 | |
| DYQRDPAITSILEKM | 201 | Q9UI42 | |
| SIYDSSMKLVREFEP | 301 | O75417 | |
| IREAFLPEDSYMDVV | 1951 | A8TX70 | |
| KDVFLEMNIPYSVVR | 821 | P01031 | |
| SEFRDKLTPITIFME | 576 | P06756 | |
| EKPSEYITAIMELSA | 216 | P98187 | |
| LPDYVRLAMLDFVSS | 661 | Q9NSG2 | |
| RMEYKDSASLPRIQD | 626 | Q3MJ40 | |
| IKASISRDPFYDMLA | 376 | O43739 | |
| MLKAPSFERGVYELT | 106 | Q7Z388 | |
| FSPYVEEAKSVLDEM | 576 | Q9P203 | |
| RLPIVNFDYSMEEKF | 66 | O94769 | |
| SMTDVKELIPEFFYL | 3286 | Q99698 | |
| NMSFRFIKRLPTEYE | 616 | P27448 | |
| YEFDVILSPELKVQM | 386 | P10911 | |
| QMEERLKEIITSYSP | 386 | O15021 | |
| DPLIYAFRSQEMRKT | 291 | P33032 | |
| FYRVLTSDVEKFMPI | 121 | Q16798 | |
| YSTDKLIIENRDMPR | 76 | Q9HD34 | |
| RQIAEAYDVLSDPMK | 46 | P59910 | |
| IDREKAMSRPILYSN | 2861 | Q14204 | |
| MARFYSPATIFIDEI | 296 | O75449 | |
| DFGYMVKLLTDSRLP | 161 | Q9UFF9 | |
| ESPLMYEDSILAVRK | 131 | P32881 | |
| EKLFDLVRRMLEYDP | 446 | Q9HAZ1 | |
| FKLDYDSMEREIAEP | 786 | Q9Y613 | |
| LQIRYLPEDFMESLK | 131 | Q14289 | |
| RMEYKDSASLPRIQD | 626 | A2RUR9 | |
| TLVREEVIDFSKPFM | 496 | P42261 | |
| DEYIKFLRSIRPDNM | 71 | Q92769 | |
| FLRSIRPDNMSEYSK | 76 | Q92769 | |
| PDKRYAMVLFRITSV | 246 | Q99679 | |
| YKLQMIEVPVLSDDS | 621 | Q92902 | |
| DNAPRTIFIISMYKD | 76 | Q14116 | |
| MDTYLGQFPDIKSRI | 126 | O00499 | |
| VRTIYESKMIEYDPE | 196 | O60832 | |
| YDRTVRVFEVMLPEK | 3541 | Q9NZJ4 | |
| FSIPETIRRDVYKMQ | 1556 | Q6ZTR5 | |
| MLEEALRSESPYQRK | 356 | Q8TEX9 | |
| EKELSGMYRRLFEPL | 121 | Q8NE79 | |
| RYFDKETRVLEAPMT | 881 | Q9C0B2 | |
| AFQDYIKLMPLVSEA | 531 | B7ZC32 | |
| LTTKEYMREVTTIDP | 1156 | Q14562 | |
| NSPRKEVYFMAIIDI | 346 | P48426 | |
| ISLPEKIQSYERMEF | 196 | Q86XI6 | |
| ALFLTVDPYMRVAAK | 41 | Q14914 | |
| LFAKTRYPDIFMREE | 56 | P32243 | |
| SVMALDRYVAISKPL | 116 | Q8NGI6 | |
| SFVKSHIRPYMDEIV | 1021 | P42345 | |
| ESVYPVMTEEEFALK | 241 | A6NES4 | |
| DFVQRAMDYFPKIEI | 641 | Q96P20 | |
| AMDYFPKIEINLSTR | 646 | Q96P20 | |
| FEYGRPTVMVLEKSL | 141 | Q96CW9 | |
| AFELVYSPAIKDSTM | 151 | P78346 | |
| TPIIFKEENLRTMYS | 206 | P82650 | |
| EYSQAEMKILPIRAA | 916 | A6NKG5 | |
| SLYLDSRKLPMIDFV | 141 | Q16563 | |
| IYKPLLFMDLLDERT | 646 | Q969X6 | |
| LKELDSPFRLYGLTM | 736 | Q8N3S3 | |
| VVLTEKDLLIYDSMP | 346 | Q13884 | |
| RLIMLDPYKIFTHDS | 136 | Q32P41 | |
| EKMCIEIVSLAFYPE | 1116 | Q96KN7 | |
| DLTVPFARYLAMNKV | 131 | P49590 | |
| LVDFLMQLEDYTPTI | 116 | Q12962 | |
| EYKNRDAISALMPLF | 1981 | O60522 | |
| MYGLPTDTIRKEFRT | 726 | Q15147 | |
| AIDSTYRKLMEDPDK | 1111 | Q8NF91 | |
| RPLQEESIMEKDYSA | 1096 | Q8WXH0 | |
| FMERYAPVAKDLASR | 326 | P31040 | |
| ELAKEMSVPFYTSRI | 41 | Q9NXC2 | |
| AAAREEDPYMDTTLK | 401 | Q969F9 | |
| SARAKYVMDVEEITP | 401 | Q6DKJ4 | |
| DIKPVTTDYFLMEEK | 2051 | Q9P212 | |
| ILYVIRDESPMKANF | 1051 | O95486 | |
| QPFMLEKDILSSYEV | 311 | Q5VZ19 | |
| YSIFADKTPEQVRME | 326 | A6NCM1 | |
| PMRATYLDDLRSKFL | 416 | Q92696 | |
| SKPERDVLMQDFYVV | 96 | O60331 | |
| PSDEVEAMTYLCRKL | 2186 | Q9NTG1 | |
| ISVLMVSKYRDILEP | 1571 | Q8NFP9 | |
| SFREKMTIPDLYFIN | 86 | Q99527 | |
| MFDKTRLPYVALDVL | 1 | O14494 | |
| IQEEMAEDPLTYKSR | 396 | Q9BYZ6 | |
| AEDPLTYKSRLMVVV | 401 | Q9BYZ6 | |
| LPRFKLEESYDMESV | 271 | P35237 | |
| PRFYEILKVMQEAAD | 521 | P08842 | |
| ELCRIPMVEYKLDSE | 1036 | Q9P2F8 | |
| MLESPSVAIYIKDES | 226 | Q5T5P2 | |
| IFDEPMDIRSAYKRL | 1446 | Q5T5P2 | |
| VRTKLEPESYLDDMV | 336 | Q7Z333 | |
| EEVKRRYMLASPDVT | 211 | P53794 | |
| YKEGDLRIMPESSES | 181 | Q99865 | |
| SDYMDLTPVDIVGKR | 351 | Q8IXF0 | |
| DFPALYSELKIMLNT | 1296 | Q8NEZ3 | |
| PIERYAMKFLEASLE | 2311 | Q6ZRS2 | |
| DITEYCPREIISLMK | 251 | Q13546 | |
| ELTFQAMSYDLLPIE | 246 | P61764 | |
| SHTFPELAYRKEMVR | 296 | Q9NSD9 | |
| PALLEIVIFYSEDMS | 411 | Q495N2 | |
| ARLEYMVKAADFPSD | 316 | Q6Q759 | |
| KSIDEGMFSAEPYLR | 1286 | Q9Y566 | |
| IVRTELSPSEEYKAM | 61 | Q9NPC3 | |
| PEELRKVFITYSMDT | 406 | O43734 | |
| EDFLTIMSYFRPIDT | 86 | Q96BS2 | |
| FLDLASLMPTDVVYV | 116 | Q8IV77 | |
| KVYDRVSVEAVLPMD | 396 | P37287 | |
| EMYSLLIDTYIRDPK | 136 | Q7LG56 | |
| KREFLFNAIETMPYV | 151 | Q7LG56 | |
| FDDIDLPSAVKYLMA | 316 | Q9Y446 | |
| KIYMEIDPVTRTEIF | 76 | Q9H2S6 | |
| VYAREMLAVKTELPE | 191 | Q9NZR4 | |
| DKTPYLTMEEITRTI | 91 | Q8N1K5 | |
| DIIESIFRTYPAVKM | 191 | P32780 | |
| EKDYLAPTTVRQLMA | 3001 | Q86UP3 | |
| RKITTYISFPLELDM | 321 | A6NNY8 | |
| KEMIDIYSTREPQLA | 461 | O43242 | |
| MSKIPADRYRVEGSF | 576 | O14924 | |
| YPEVIKLMESITDSL | 66 | Q9UMS6 | |
| EDGRLYAVKRSMSPF | 131 | Q99640 | |
| FRAMEVETYEKPQVA | 316 | Q9UHP6 | |
| EAFEETPMLVAVLTY | 61 | O15270 | |
| CMTRTDLPEKIEYVF | 146 | Q9Y5Y9 | |
| EVVDSNPYSRLMALK | 46 | Q9GZZ9 | |
| GDSDLMEPVFRYLAK | 1231 | Q96HA7 | |
| IEAIRAEYQKMPAFL | 176 | Q9BSJ1 | |
| KEPYAREMLAISFIS | 1156 | Q9P227 | |
| REERPDVDKVYMTFV | 141 | Q8TB22 | |
| YKEGDLRIMPESSES | 181 | Q9BPZ2 | |
| LETLPTEYDSRVKAM | 161 | P17980 | |
| EYLERELTMASLPFT | 311 | Q9H0D6 | |
| PDSMSFIYKALERNI | 336 | P80108 | |
| YMFDLLLETRKPDQV | 691 | Q96K76 | |
| SRYMRDKLDTLVDFP | 841 | Q9Y4E8 | |
| SADPADTEKMLRYEI | 61 | Q99727 | |
| DAGTPEDKMRLFLIY | 446 | Q8WVM8 | |
| VPDMTKRDYLVDAAT | 41 | Q9Y6S9 | |
| VSESMDFRYLPDEKD | 271 | Q04864 | |
| LASEYLTPEEMVTFK | 386 | O43290 | |
| VYEMFRKDDPRLSFT | 1801 | P78527 | |
| IIERYPEETLSLMTK | 3471 | P78527 | |
| LIKYEDSMISISRFP | 111 | Q14588 | |
| MYIRVSYDTKPDSLL | 71 | Q7Z4N2 | |
| MKDDLVPETARLNYT | 711 | Q96KM6 | |
| PLELMFVYSLEERVE | 61 | A0A589 | |
| FSIAEELIKPYLVEM | 846 | O95789 | |
| LMKEDLTPTERVYVR | 1751 | Q86YA3 | |
| ILRKDIPSFERYMAQ | 156 | P48556 | |
| PVFAEYIKCILMDER | 3211 | Q70CQ2 | |
| SVKEYRMEVPSSFSE | 3411 | Q70CQ2 | |
| FTPEMKDLINGYIRT | 541 | Q658N2 | |
| LESFYRFVLEPELMS | 1011 | Q9NYU1 | |
| AEILMQKLPDIFSVY | 906 | Q14669 | |
| PDYSSIEIMREKLLI | 1966 | Q14669 | |
| YRKPTVELLDLDTME | 511 | Q15849 | |
| MEIRVFPDKGYSFVR | 241 | P31483 | |
| YITPAQISKEMRDEL | 56 | O94874 | |
| KDIIEYLSTSFLPMA | 191 | Q9P2D8 | |
| YSEMVSLFETPRKTR | 1336 | Q5THJ4 | |
| MVIFAPRYLLDNKSS | 3396 | Q5THJ4 | |
| RRPSMFEKEAYTQIL | 31 | Q8IZS6 | |
| MEAKSPFYLTARKEA | 646 | Q8N8K9 | |
| LSVSDIIDYFRKMPL | 496 | Q13094 | |
| DEVLIYRMIPASNKA | 461 | Q9ULH4 | |
| AIFVTDRHLYKMDPT | 876 | O94832 | |
| PESLFLLEEMRERKY | 681 | Q12965 | |
| EPSMKIIADIFEYTA | 236 | P22033 | |
| DIMRLITKDLSEPYS | 226 | Q147X3 | |
| RSPRYAVFDLMEGKS | 566 | P54296 | |
| ELPMLTYRVDADKGF | 371 | Q9Y2G1 | |
| YETFEDLREKLLMAV | 951 | Q96PU5 |